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INTRODUCTION 

In spite of all research efforts in diagnosis, therapy 
and epidemiology, breast cancer incidence and mortality 
showed no decrease during the last decades (1). Neither the 
different surgical procedures nor the introduction of hor­
monal therapy and the various chemotherapeutic agents, which 
proved to be highly effective in some other malignancies, 
have reduced the mortality of this disease. It is likely 
that when the tumor is discovered in a stage, in which 
distant spreading of the disease already took place, the 
different therapeutic measures will at best postpone death 
but not prevent it. It was therefore logical to make every 
effort to discover the tumor prior to its spreading. Mam­
mography seemed to be the most promising diagnostic tool in 
achieving this goal. 
Introduced by Salomon in 1913 (2) it has been developed 
in the past 20 years into a highly sensitive diagnostic 
method that is capable to detect invasive and even prein­
vasive breast cancer in its preclinical stage. It was 
rational to introduce this diagnostic tool in the screening 
of asymptomatic women with the aim to discover the disease 
in a stage in which it is still curable. The results of a 
mass screening for breast cancer from a randomized trial in 
the United States (the so-called HIPX study, (3) were 
promising. They showed a significant difference in fatality 
χ Health Insurance Plan 
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rate between the screened and the control groups of women 
aged 50 to 59 in favour of the screened women. Encouraged by 
these results, some other screening projects were started in 
the U.S. and Europe, such as the screening program of the 
BCDDP , U.S. (4), that of Sandviken (5), Malmö (6) and 
Kopparberg (7) in Sweden, and that of Utrecht (8) and Nijme-
gen (9) in the Netherlands. All these screening programs 
were in fact research projects. Their aim was to reproduce 
the results of the HIP study and to try to show a benefit in 
terms of a decrease of fatality rate also in other age 
groups than that of 50 to 59. The rapidly improving tech-
nique of mammography was the credit for this aim. 
The screening program in Nijmegen started in 1975. 
In this program about 30.000 women have been screened by a 
periodical mammographie examination with a two-year interval. 
The patients, who were referred to the surgeon on the basis 
of suspicious mammographie changes, were operated in the two 
hospitals of Nijmegen. 
Due to the screening program a quite new situation de-
veloped with respect to the diagnostic and treatment pro-
cedures of these patients. For instance, the surgeon had 
to become accustomed to the excision of mammographically 
suspicious but clinically occult lesions. The pathologist 
had to learn to examine biopsies with mammographically 
suspicious but grossly invisible lesions. Furthermore, he 
had to become familiar with the so-called borderline lesions 
since many of the clinically occult lesions, discovered by 
the screening were of this type. To monitor continuously the 
basic parameters such as the sensitivity and specificity of 
the screening and to evaluate its results in general, co-
operation with the epidemiologist was mandatory. It was 
obvious that a team consisting of the radiologist, the sur-
geon and other clinicians, the pathologist, the radiothera-
pist and the epidemiologist was a prerequisite to cope with 
the new tasks created by the screening. 
xx Breast Cancer Detection and Demonstration Project 
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The task of the pathologist was two-fold: 
1. To introduce an efficient diagnostic procedure for 
the study of biopsies and mastectomy specimens, suitable to 
provide detailed and reproducible data on the type, exten-
sion, spreading and possible multifocality of the lesions. 
2. To use the collected material for research purposes. 
The topics for the studies were chosen on the basis of 
practical problems concerning breast cancer diagnosis and 
therapy. 
Chapter 1 deals with the description of the method 
introduced. 
One of the most distressing aspects in screening pro-
jects for breast cancer is the almost regular appearance of 
so-called interval cancers: cancers discovered between two 
screening examinations. Interval cancers have a strongly 
negative effect on the results of mass screening projects 
because: 
1. Many of them are discovered in a clinically more 
advanced stage than that of the cancers found by screening 
examinations. 
2. They have a rather bad psychological effect on the 
study group of the invited patients, as they reduce the 
confidence in the reliability of the mammography and may cause 
a decrease in the percentage of the responding women. 
Chapter 2 deals with the pathologic and radiologic 
analysis of 64 interval cancers of the Nijmegen screening 
project. The reasons why these cancers were not detected at 
the preceding mammographie examination were studied. It is 
also discussed in which way the number of the interval 
cancers might be reduced to an acceptable minimum. 
The study of the interval cancers drew our attention 
to a group of cancers which fail to produce suspicious 
changes on the mammogram, that is, they are radiologically 
occult. One part of these tumors is clinically symptomatic, 
another part is both clinically and mammographically occult. 
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The fact that these cancers are mammographically silent may 
cause a significant delay in their diagnosis. 
Chapter 3 deals with the pathologic and radiologic 
aspects of the mammographically occult breast cancers and 
analyzes their consequences on tumor diagnosis in both 
symptomatic and asymptomatic patients. 
The well-circumscribed round shadows on the mammograms 
may cause a differential diagnostic problem. They may be 
the radiologic sign of both benign lesions such as a cyst 
or a fibroadenoma and malignant tumors such as a medullary 
carcinoma or a metastatic mass. Echography proved to be a 
reliable method in the differential diagnosis of these 
lesions. In a study of the pathology of breast lesions with 
round mammographie shadows we discovered 6 cases of a pe-
culiar type of breast cancer with osteoclast-like giant 
cells. So far, 15 cases of this type of tumor have been 
published (10). 
In Chapter 4 the morphologic aspects and the clinical 
features of this special type of breast cancer are dis-
cussed. 
As mentioned before, the type of standard surgical 
treatments, offered to the patients with breast cancer, did 
not influence the mortality rate of the disease signifi-
cantly. In a randomized study, Fisher and associates (11,12) 
showed that no significant difference was found in terms of 
distant metastasis and mortality between patients treated 
with Halsted radical mastectomy and those with total mas-
tectomy. Moreover, the randomized study of Milan (13) in-
dicated that even a segmentectomy, followed by local radi-
ation therapy in patients with small tumors (< 2 cm), is not 
inferior in terms of rates of distant metastasis and mor-
tality when compared to radical mastectomy. On the basis of 
these results, some randomized and non-randomized trials 
have been started offering breast conserving surgical ther-
apy with or without post-operative radiation therapy. They 
14 
show differences in the extent of the surgical excision and 
in the size of the tumor that is meant to be treated. 
One of the main problems which comes up in these trials 
concerns the uncertainty about the amount of tumor that may 
remain in the breast after excision of the reference tumor. 
The residual tumor may serve as a potential focus of local 
recurrence. The correlated histologic and radiologic method, 
used in our laboratory for the examination of mastectomy 
specimens (Chapter 1), provides an excellent means to obtain 
detailed information on the distribution of the occult tumor 
foci around the reference tumor. Based on the study of these 
mastectomy specimens we estimated the amount of tumor foci 
which may remain in the breast after the various breast 
saving surgical procedures. 
Chapter 5 deals with the study on the multifocality 
of breast cancer and its implications for the clinical 
trials of breast conserving surgical therapy. 
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CHAPTER 1 
Some Aspects of the Procedure in the Pathologic Breast 
Cancer Diagnosis in the St. Radboud Hospital, Nijmegen. 

The introduction of mass screening for breast cancer 
in Nijmegen created new aspects in the clinical and patho-
logic diagnosis of breast lesions (Fig. 1). About 40% of the 
cancers, discovered by the screening examinations in this 
project, had a size of less than 1 cm, 60% were clinically 
occult and 30% were found solely on the basis of mammo-
graphie microcalcifications (1). For the excision of the 
clinically occult lesions the needle localization technique 
was introduced (2). Through this method, the radiologist 
marks the lesion with a fine wire under mammographie control 
prior to excision. During the bioptic procedure, the surgeon 
will then be guided by this wire. Subsequently, radiography 
has to be performed on the biopsy both in toto and after 
slicing of the specimen. On the basis of the radiograms the 
surgeon will be informed as to whether the specimen contains 
the radiologically suspicious lesions and the pathologist 
then can easily locate the lesion for histologic examination 
(Figs. 2A-D). We prefer to perform specimen radiography not 
only on biopsies with clinically occult lesions, but even on 
many of the biopsies with clinically palpable lesions. The 
specimen X-ray proved to be an excellent guide at the sam-
pling of tissue blocks for histologic examination and at 
verifying the site of the lesions and their extent. The 
grossly non-visible tumor foci around the reference tumor 
can often be traced on the basis of such a specimen radio-
gram. Furthermore, a specimen X-ray is indispensable for 
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THE USUAL PROCEDURE OF PATHOLOGIC DIAGNOSIS 
OF BREAST CANCER IN THE St. RADBOUD HOSPITAL. NIJMEGEN 
Clinical ly suspect lesions 
Mam mo-
graphically 
occult 
Mammographically suspect lesions 
Clinically 
occult 
FS on the infraclavicular 
ax i l l a ry nodes 
\e 
Total mastectomy 
Mastectomy and axillary dissection 
Extensive pathologic examination 
accompanied by specimen radiography 
Breast saving surgical procedures 
Segmentectomy and ax i l la ry dissection. 
FS on the tumor mass if foregoing 
pathologic examinations were negative. 
Extensive pathologic examination 
accompanied by specimen radiography 
** 
Obtain tissue for receptor studies at any stage ! 
FS = frozen section 
*No f rozen section but permanent section diagnosis if the tumor is less than 
5 mm or it is discovered solely by mammographie microcalcifications 
In case of clinically occult lesions specimen radiography of the biopsy is 
mandatory 
F I G . 
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orientation when in breast saving surgical procedures the 
pathologist has to report on the involvement of the surgical 
edges and on tumor multifocality of the excised breast 
segment. For a proper orientation the surgeon should mark 
its 12 and 6 o'clock points and the ventral or caudal face. 
Surgeon and pathologist sometimes differ in opinion 
as to which of the lesions are suitable for frozen section 
diagnosis and which are not. Clinically occult lesions, 
for example those, which are detected solely on the basis of 
mammographie microcalcifications, are, in general, unsuitable 
for this diagnostic technique. Such lesions often concern 
intraductal proliferations which may cause considerable 
diagnostic problems even in paraffin sections. Even when the 
lesion is histologically an obviously malignant intraductal 
proliferation, a thorough examination of multiple paraffin 
sections is needed to rule out occult invasive growth. 
Furthermore, one should be aware, when using the frozen 
section technique in cases with microcalcifications, that 
they might easily be missed due to an improper orientation 
of the tissue block (Fig. 3). 
Very small solid tumors (< 5 mm) may cause diagnostic 
problems when they have to be differentiated from sclerosing 
ductal adenosis. It is safer to study these lesions in 
paraffin than in frozen section. For all these reasons we 
are not inclined to perform frozen section diagnosis on 
lesions which were discovered solely on the basis of mammo-
graphie microcalcifications and on solid lesions less than 
5 mm of size. 
For many decades frozen section diagnosis has been the 
routine measure immediately prior to mastectomy. This was a 
logical procedure in a time when mastectomy was practically 
the only surgical treatment for breast cancer. The pathol-
ogist's statement that the lesion was malignant, used to be 
sufficient to proceed to the operation. In the present time 
in which various conservative treatment modalities alter-
native to mastectomy exist, more information is needed to 
choose the most suitable treatment for the individual pa-
tient. Frozen section diagnosis often fails to provide all 
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FIG. 2A. Mammogram showing an area with suspicious micro-
calcifications (t)· A fine wire marks this area. 
FIG. 2B. Specimen radiogram of the biopsy with the same 
area with microcalicifications. 
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FIG. 2C. Tissue slices of the same biopsy. Grossly no 
obvious supsicious lesions are visible. 
FIG. 2D. Specimen radiogram of the tissue slices shown 
in Fig. 20. Note the area with the suspicious microcal-
cifications ( t) . 
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FIG. 3. Radiogram from two directions of a tissue block 
embedded in paraffin. Note the microcalcifications which 
lie at the bottom (B) of the block. At frozen section 
diagnosis in which usually only superficial sections are 
investigated, this lesion could have been missed easily. 
the necessary information. Moreover, we have to abandon the 
idea that frozen section diagnosis, if positive, should 
oblige the surgeon to proceed directly to an operation. This 
technique should rather be regarded as a fast diagnostic 
method to provide basic information by which time is gained 
for making the right decision concerning the diagnostic and 
therapeutic steps to be taken preferably with the partici-
pation of the patient herself. 
For cases of clinically obviously malignant tumors 
in which the cytologic examination fails to reach a defi-
nitely positive diagnosis, we recently introduced the frozen 
section diagnosis on needle biopsy. These tumors usually are 
invasive lobular cancers with fairly extensive growth which 
may lack obviously malignant cytologic features. 
Since 1978 we have been studying the mastectomy speci-
mens with the so-called correlated histologic and radiogra-
phic technique used earlier by a few investigators (3-5) and 
known in the literature as the Egan's method. Through this 
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technique the mastectomy specimen is chilled overnight in a 
refrigerator to about 2 С and sectioned macroscopically at 
about 5 mm with an ordinary meat-slicer. Subsequently, a 
radiograph of each macrosection is made. Prior to section­
ing, the specimen is carefully oriented with the help of the 
12 and 6 o'clock points previously marked by the surgeon. 
These two points are connected with a superficial marking-
cut through the nipple. 
Tissue blocks for histologic examination are taken 
from the grossly and radiologically suspicious areas, and 
also some randomly selected ones from each quadrant and the 
nipple. On average, 20 blocks of each breast specimen are 
obtained. The sites of the tissue blocks as well as the 
microscopically verified extension of the lesion, are in­
dicated on the X-ray (see Chapter 5, Figs. 1A-D). Further­
more, both the histologic type and size of the tumor foci 
are recorded in the photos. The distance between the margin 
of the reference tumor (the tumor which directed the biopsy 
or the cytologic examination) and each of the other tumor 
foci are determined. By these measurements the following 
points of reference on the radiographs are used: (1) the 
breast slice with the largest cut surface of the nipple as 
the margin between the upper and lower quadrants, (2) the 
marking-cut at the 12 o'clock point on each slice indicating 
the border between the outer and inner quadrants and (3) the 
given thickness of approximately 5 mm of each gross slice. 
All measurements and data of the radiographs of each 
breast specimen are then transferred to a topographic 
diagram with a frontal projection and coded so as to be 
suitable for computer analysis. This method makes it poss­
ible to collect reproducible data on both extension and 
site of the various lesions in the breast and on their 
topographic relation to each other. The method is expensive 
and time-consuming and therefore not suitable for routine 
use. 
The specimen mammograms were performed on a Senographe 
unit (Compagnie Générale de Radiologie, Paris) using Kodak 
Min-R screen and film. 
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Since 1979 the mastectomy specimens obtained in the 
two hospitals of Nijmegen (about 150 cases per year) have 
been studied with the above mentioned procedure in one and 
the same laboratory. 
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So-Called Interval Cancers of the Breast 
Pathologic and Radiologic Analysis of Sixty-Four Cases 
ROLAND HOLLAND, M D , · MARCEL MRAVUNAC, M D . t JAN H C L HENDRIKS. M D . * 
AND BERNARD V BEKKER, M D § 
Within a population-based breast cancer screeaing program, 209 cancers were detected by regular 
mammographie screening. Additionally, 66 cancers were discovered between two conseculire screenings 
after one, two, or three negative screening examinations (interval cancers). The study group consisted 
of 25,920 women who have been participating since 197S in a breast cancer screening program in 
Nijmegen, the Netherlands. In this program, single view mammography (lateromedial projection) was 
administered as the sole screening examination every two years. Physical examination was not part of 
the screening program. All previous histologic and radiologic material from 64 of those "interval" 
patients was available and was reviewed. In 19 of the 64 patients, direct or indirect signs of tumor were 
seen on the previous screening mammogram on review (observers error). In four cases, the site of the 
tumor lay outside the imaging field (technical error). In 41 cases, no signs of tumor could be seen on 
the mammograms even oa review. By calculated tumor doubling times, 20 of these 41 cases were probably 
too small to be detected at the last screening ("real" Interval cancers). However, 21 cases were probably 
large enough but were somehow masked from radiologic detection. The main reasons for this "masking" 
proved to be: 1) dense breast, 2) poorly outlined tumor mass of diffuse infiltrative type, mainly invasive 
lobular carcinomas, and 3) intraductal localization. The authors suggest that women with dense breasts 
be screened more frequently, using more views and modalities and with broader criteria for advising 
surgical biopsy. They also note (hat in general the two-year interval between screenings is probably 
longer than the optimal iaterval. 
Cancer 49:2527-2533, 1982. 
ONfc оь T H E C O M P O N E N T S of the sensitivity of a population-based breast cancer screening pro­
gram is the number of so-called interval cancers in the 
screened population ' As generally used, the term " i n ­
terval cancer" denotes those cancers discovered between 
two screening examinations after a previous screening 
considered negative (insufficient changes to recommend 
a biopsy) In several of these interval cases, an obvious 
diagnostic error might be delected on retrospective re­
view of the "negative" mammogram, whereas in an-
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other group of cases, careful analysis of various less 
specific signs in the mammogram might lead to the 
suspicion of a cancer : There wi l l , however, remain a 
group of cases in which no pathologic changes on ret­
rospective review of the previous mammogram can be 
seen This group constituted 70% of all interval cases 
in our study Some of these cases, with a relatively small 
tumor at diagnosis and relatively long interval between 
time of diagnosis and last screening, might be incidence 
cancers, growing between two screenings above the size 
of radiologic detectability, 5-6 mm On the contrary, 
relatively large tumors diagnosed shortly after the last 
screening examination might well have been present at 
this threshold size or even larger at the last screening, 
but were somehow masked from radiologic detection. 
( A n exception tn this group would be exceptionally fast-
growing tumors ) Considering that some types of breast 
cancers may be completely occult radiologically,3 this 
hypothesis seems plausible. The present study analyzes 
the reasons interval cancers, i f present, failed to show 
radiologic signs of tumor In addition, those cases 
proven to be observer's errors on review are analyzed. 
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s 
FIG I Well-outlined, discrete lump of an invasive ductal carcinoma surrounded by fìbrous parenchyma (H & E. x 3 ) 
Patients and Methods 
The study group consisted of 25,920 women who have 
been participating in a breast cancer screening program 
starting in 1975, ш Nijmegen, the Netherlands, Up to 
December 1980, there have been three screening ex­
aminations performed with a two-year interval Single 
view mammography was used in the lateromedial pro­
jection. Physical examination was not part of this 
screening program, although participants were trained 
in self-examination and reported their findings at 
screening. In addition to the 209 cancers detected by 
mammographie screening, 66 cancers were found be­
tween two consecutive screening examinations, after 
one, two, or three negative screening examinations. All 
but one of these cancers were symptomatic, and all but 
three were discovered by the patient herself. Sixty-seven 
percent of the patients reported regular self-examina­
tion of the breasts. All available histologic slides and 
radiographs from each patient were reviewed In two 
cases, one or the other was unavailable. 
Morphologic Analysis 
Except for very large tumors, the tumors were totally 
embedded. On the average, about 20 blocks were taken 
from each mastectomy specimen. In 33 of the 64 cases, 
the mastectomy specimen was macroscopically sec­
tioned at 5-6 mm A radiograph of each macrosection 
was made. Histologic slides were taken from both the 
grossly and the radiologically suspicious areas The fol­
lowing morphologic characteristics of each tumor have 
been recorded I) the largest diameter of the tumor 
mass. 2) whether the tumor mass was a relatively welt-
outlined. discrete lump ( Fig, I ) or rather a diffuse tumor 
proliferation without clearly definable borders (Fig. 2), 
3) whether the invasive areas consisted mostly of foci 
of solid or cribriform growth or rather of evenly dis­
tributed tumor cells and tumor cells in cordlike pattern 
(ductal versus lobular invasive pattern). 4) mitotic 
rate—cancers were divided in three groups according 
to number of mitoses per 400 tumor cells: Grade Ι, Ο­
Ι . Grade 2, 2 3. and Grade 3. э=4 mitoses per 400 tumor 
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t -fi -
*ч 
F I G 2 Poorly outlined tumor mass of a diffusely mliltrating s 
tumor (H & E. x 3 5) 
ibdreolar lobular carcinoma mainly in fibrous parenchyma (U fields with 
cells. Counting of mitoses has been done on the invasive 
component of the tumor, if present; and 5) whether an 
in situ tumor localization, if present, was lobular or 
ductal. 
A cancer was regarded as invasive lobular carcmoma 
if all of the following three conditions were present: 1 ) 
characteristic cytologic features of tumor cells as small 
round nuclei with inconspicuous nucleoli and nuclear 
Grade 3 or 2. well- and intermediately differentiated. 
respectively: 2) characteristic features of invasive pat­
tern as diffuse spread and linear arrangement of tumor 
cells; and 3) the presence of in situ lobular neoplasia 
anywhere in the breast. 
The density of the breast was recorded according to 
Wolfe's classification/ and this classification was used 
to evaluate the suitability of the breast for mammo­
graphie interpretation s 
Tumor volume doubling time was calculated by the 
following formula: 
0.1T 
DT 
log — 
do 
where DT = volume doubling time, Τ » number of days 
between mammograms, d0 • initial diameter, and dT 
• diameter after Τ days 
Results and Discussion 
From the 66 cancers, almost equal numbers of tumors 
were discovered after the initial and after the second 
screening, with rates of 1-2 and 1.7 cancers per 1000 
participants per two years, respectively (Table 1 ). The 
Breast Cancers Found after Initial and 
Subsequent Screenings 
Mean post-
Rate/1000 screening 
No of No of participants/ follow-up 
cases participants 2 years period (mo ) Screening 
Initial screening 31 + I* 25,920 
2nd screening 2 8 + 1 ' 17.288 
3rd screening 5 12.721 
1.2 
1 7 
244 
24 
1? 
' Lack of histology material or radiograph 
3 1 
TABLI- 2 Results of Rclrospeclive Review of 
Screening Mdmmograms 
Direct or indirect signs 
of tumor 
No signs οΓ lumor 
19 
45 
30 
70 
low number of cases discovered after the third screening 
(five cases), is explained in part by Ihe shorter mean 
time of follow-up in this group 
Table 2 shows the results of retrospective review of 
the last screening mammograms In 19 cases or 30%, 
direct or indirect signs of tumor were seen on the most 
recent screening mammogram However, in 45 cases 
or 70%, no signs of tumor could be seen even on review 
Although one would expect that most of these cases 
were incidence tumors, analysis of the size of these tu­
mors at diagnosis, their interval after last screening, 
and their mitotic rate, as a possible marker of the speed 
of growth, made this simple explanation seem unlikely 
Table 3 compares these characteristics in the 19 cases 
that showed signs of tumor on review of the mammo­
gram, that is, they proved to be present at the last 
screening, with those 45 cases without such mammo­
graphie signs There was no significant difference be­
tween the two groups in the mean size of the tumors 
at diagnosis or in mitotic count (as an indicator of rale 
TABLE 3 Selected Characteristics of Tumor with Last Screening 
Mammogram Positive or Negative on Review 
No of cases 
Size οΓ tumor al 
diagnosis (mm) 
Mean 
Range 
[nlerval since last 
screening (mo ) 
Mean 
Range 
Rate of milosist 
(mitoses/400 
tumor cells) 
0 1 
2 5 
г 4 
Last screening 
mammogram (by review) 
Positive Negative 
19 45 
16 29 
15-110 10-100 
10 15 
3 22 1-24 
6 24 
9 15 
3(17%) 6 ( 1 3 % ) 
Ρ 
NS· 
<0 0|· 
N S t 
* Student's paired / lest 
t Cht square test N S = Ρ > 0 05 
f Not counted in one case of malignant cystocarcoma phyllodes 
of growth) Although the mean interval of the mam­
mogram negative tumors was longer than that of the 
mammogram positive cases, the broad variability in 
both groups of this interval between last screening and 
the discovery of the tumor made it seem likely that at 
least some of the mammogram negative tumors were 
in fact present at a radiographically detectable size at 
the last screening mammogram 
To divide those cancers that were probably of a ra-
diologically detectable size, 5-6 mm or larger, from 
those below this l imit at the last screening, we consid­
ered first all cancers with mitotic rate of four or more 
mitoses per 400 tumor cells as incidence cancers, re­
gardless of their size at diagnosis or the length of in­
terval The remaining 39 cases were considered tumors 
with intermediate or low rate of growth, and they were 
further analyzed We posed a hypothesis that all these 
tumors were 6 mm in diameter at the last screening 
mammogram Given the data that we had for each tu­
mor on size at diagnosis and time interval since the last 
mammogram, what would the tumor doubling time 
have to be for each tumor'' Figure 3 shows the tumors 
rank ordered according to these calculated doubling 
times Clearly, some of the short doubling times are 
highly unlikely We chose a threshold doubling time of 
88 days This doubling time is about at the border be­
tween intermediate and short doubling times for breast 
cancers as reported by other investigators 6 * Using this 
threshold calculated doubling time, we identified 25 
tumors with doubling times as short as to have probably 
been present at the last screening mammogram at a size 
of 6 mm or greater, that is, within the radiologically 
detectable size range This group was reduced by four 
cases when it was discovered on review that the tumor 
site lay outside the imaging field Two of these tumors 
were situated extremely laterally and two of them ex­
tremely medially at the border of the upper and lower 
quadrant, all four in the right breast Thus, there re­
mained 21 cases, or 33% of the total interval cancers, 
for which the question had to be answered although 
apparently large enough, why were these cancers ra­
diologically occult at screening'' 
Table 4 shows additional characteristics of this group 
of cancers Ten of these 21 cases showed a poorly out­
lined tumor mass of diffuse infi ltrating type on histol­
ogy, and of those ten cases, in nine the only or the 
dominant histologic type of tumor was invasive lobular 
carcinoma A l l but two were situated in dense breast, 
poorly suited to mammographie interpretation The 
mean size of these tumors at diagnosis was 46 mm Four 
of them failed to present a tumor shadow on the mam­
mogram even at surgery, three of the four were com-
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pletely occult radiologically Nine of the 21 cases 
showed d better outlined tumor mass or discrete lump 
on pathologic examination Among these tumors, in 
eight cases, the only or the dominant histologic type of 
tumor was invasive ductal carcinoma Their mean size 
at diagnosis was 24 mm, and two of them were com­
pletely occult radiologically even at surgery A l l but two 
were situated in dense breast The remaining two cases 
were intraductal cancers None of ihem had a tumor 
shadow at surgery The mean lime after last screening 
did not differ significantly among the three groups and 
was around one year 
We concluded from these data that intraductal can­
cers may be occult radiologically unless they produce 
calcifications or other indirect signs The radiologically 
detectable size of invasive breast cancers is about 5 mm 
diameter to most investigators There are, however, at 
least two factors that can significantly influence this 
threshold of delectabihty the pattern of the breast and 
the type of tumor mass This threshold size of a cancer 
situated in a dense breast (pattern P2 and DY) can be 
20 mm if it is a tumor mass of a lump type (Fig I ) 
and can be even several centimeters in case of a tumor 
mass with diffuse spreading of cancer cells (Fig 2) 
Tumors with diffuse spreading of cancer cells produce 
little fibrous tissue, and this is mostly evenly distributed 
as are the tumor cells themselves 
Table 5 shows some characteristics of the patients 
and their tumors of all interval cancers with lump type 
and diffuse type of tumor mass Sixty-nine per cent (9/ 
13) of the patients with diffuse tumor mass were pre­
menopausal, compared with only 37% (17/46) of those 
with lump type tumor mass Those cancers with diffuse 
tumor mass were predominantly invasive lobular car­
cinomas with low mitotic rale, those of lump type were 
mainly invasive ductal carcinomas The mean size of 
tumors when they were discovered by the patients was 
more than twice as large if it was a diffuse type in 
comparison with a lump type of tumor mass, ι e, 49 
and 23 mm, respectively From those diffuse tumors, 
46% (6/13) failed to present a tumor shadow on the 
mammogram even at surgery, compared with only 4% 
(2/46) of discrete lumps There was a clear difference 
between the two groups in the percentage of positive 
axillary nodes as well Among those patients in whom 
surgical dissection of axillary nodes was performed, 
607c (6/10) had positive nodes if the tumor mass was 
diffuse and 45% (9/20) if it was a lump 
The group of 19 cases showing diagnostic errors in 
mammogram interpretation reflects rather well the 
groups described by Mart in et al7 as the obvious and 
less obvious mammographie errors (Table 6) From 
DOUBLINGTIMEIDAYSI 
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¿0 
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CUMULATIVE FREQUENCY 
0 10 20 30 40 SO 60 70 Θ0 90 100 
CUMULATIVE RELATIVE FREQUENCY 17.) 
He: Э Interval cancers without signs of lumor on screening mam­
mogram on renew rjnk ordered by calculated lumor volume doubling 
time (Cancers with 5=4 mitoses per 400 lumor cells were excluded 
from ihis group ) Data for this calculation were diameter of lumor 
al diagnosis a hypolhetical diameter of 6 mm al the lime of last 
screening mammogram and lime interval between diagnosis and last 
screening Λ threshold doubling time of BB days was arbitrarily chosen 
Twenty five tumors had л shorter calculated doubling lime than this 
threshold 
T A B L E 4 Interval Cancers Probably 6 mm or Larger at LBS! 
Screening without Paihologic Signs on Screening 
Mammogram on Review 
Number of cases· 
Histologic type 
IDC or IDC + Comb 
1LC or ILC + Comb 
1DCA 
Breast pattern 
N1 & PI 
P2 i DY 
Size оГ tumor at 
diagnosis (mm) 
Mean 
Range 
No tumor shadow at 
diagnosis 
Interval (mo ) 
Mean 
Range 
Diffuse 
10 
1 
9 
2 
S 
46 
20 80 
4 
I I 6 
4-21 
Tumor mass 
Lump 
9 
8 
1 
2 
7 
24 
10 80 
2 
13 
5-20 
Unspecified 
2 
2 
1 
1 
60 
20, 100 
2 
125 
2 23 
* Excludes those four cases with technical error IDC ^ invasive 
ductal carcinoma ILC - invasive lobular carcinoma, I DC A - intra­
ductal carcinoma Comb - combinations of two or more types das· 
sified b> dominant type Breast patterns by Wolfe s classification * 
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TABLE S Characteristics of the Patients and Their Tumors of 
all Interval Cancers Comparison of Diffus« and Lump 
Type Tumor Mass" 
Age οΓ patient 
40 50 
>50 
Menopause 
pre 
post 
Rate οΓ mitosis (mitoecs 
pei 400 tumor 
cells) 
0 1 
2-3 
i-4 
Histologic type of tumor 
IDC or IDC + Comb 
ILC от ILC + Comb 
Breast pattern 
N1 A P I 
P2 4 DY 
No shadow on 
mammogram at 
time of diagnosis 
Mean size of tumor at 
diagnosis (mm) 
Status of axillary nodes 
Dissection not done 
Negative for tumor 
Positive for tumor 
No of 
diffuse 
mass 
12 
M 
I I 
49 
Tumor 
Per cent 
69 
31 
69 
31 
SS 
es 
46 
20-1 lot 
40 
60 
mass 
No 
of 
lumpy 
mass 
13 
33 
17 
29 
IS 
21 
9 
43 
Î 
18 
28 
2 
23 
26 
11 
9 
Per cent 
26 
74 
37 
63 
4 
57 
4 
10 70t 
55 
45 
* Excludes five cases of intraductal carcinoma since they had nei 
ther a diffuse nor a lump type tumor mass 
t Nol counted in one case of malighant cystoiarcoma phyllodes 
t Range 
IDC = invasive ductal carcinoma ILC = invasive lobular caret 
noma [DCA ж intraductal carcinoma Comb » combinations of two 
or more types classified by dominant type Breast patterns by Wolfe s 
classification 4 
those ten cases with tumor nucleus shadow on retro­
spective review, six had no obvious malignant radiologic 
signs In four of these six cases, comparison of the pre­
vious mammograms could have led to the right conclu­
sion based on the development of a new shadow Three 
of these tumors were invasive ductal carcinomas of cir-
cumscnpl type on histologic examination, and one of 
them was a combination of an intraductal carcinoma 
and an invasive ductal carcinoma with an invasive com­
ponent of about 30% In another case with an uncertain 
density on the mammogram, radial lines were seen lead­
ing to the nipple This tumor was an intraductal car­
cinoma on pathologic examination Another "benign" 
shadow proved to be malignant cystosarcoma phyllodes 
histologically From those two cases without "malignant 
signs" of calcifications on the screening mammogram, 
one was an intraductal carcinoma and the other an in­
vasive ductal carcinoma on histologic examination, both 
of them with intraductal calcifications One case with 
dilatation of ducts on the last screening mammogram 
proved to be an intraductal carcinoma with Paget's 
disease on histology 
A baseline mammogram for comparison is essential 
in the radiologic evaluation of this group of tumors 
without obvious malignant signs 
Considering two aspects of the screening program's 
design, namely the two->ear interval between screenings 
and the lack of routine clinical examination, we ask two 
additional questions Would annual screening and/or 
physical examination have contributed to the earlier 
diagnosis of these interval cancers'' Both answers can 
only be theoretical 
1. Figure 4 shows those 45 cases without pathologic 
signs on the screening mammogram on review Among 
them, 28 cancers or 62% had an interval between 12 
and 24 months These interval cancers could theoreti­
cally have been detected by an additional annual screen­
ing I f we deduct from this group of 28 those three cases 
with high mitotic rate, those three radiologically occult 
TABLE 6 Direct or Indirect Signs of Tumor on Retrospective 
Review of Screening Mammogram 
No tumor nucleus 
shadow 
Nipple relrac-
Tumor lion or 
nucleus Calcifi dilatation of 
shadow cation ducts 
TABLt 7 Reasons for Missed Detection on 
Screening Mammogram 
ОЬ юиі diagnostic 
ertoi 
Less obvious 
diagnostic error 
10 
9 
4 
6 
4 
2 
2 
1 
localudtion 
Tumor too small 
TOTAL 
Observer error 
Technical error site of tumor lay 
outside imaging field 
Tumor large enough but masked from 
detection by dense breast and/or 
diffuse tumor mass or by intraductal 
* real interval cancers 
21 
20 
64 
30 
6 
33 
31 
100 
34 
1 2 3 i S Б 7 β 9 13 l i 12 Π 1¿ ft * 17 β 19 20 21 22 2 3 2 4 
INTERVAL BETAEEh LAST SCREENING AND »AGNOSJS (MOS) 
Fio 4 Interval cancers without signs of lumor on the Idsi screening 
mammogram on review · =afour mitoses per 400 tumor cells D 
radiologicallv occult at diagnosis DifT (umor mass of diffuse invjsive 
type О breast pattern N1 or PI · bredsl pattern P2 or DY Τ 
technical error Encircled cases are those thai could probably have 
been detected bv an additional annual screening (sec text) 
at diagnosis, those ten cases too small at diagnosis and 
situated in a dense breast or with a diffuse invasive 
pattern, and finally that one with technical error, we 
come to a group of 11 cases or 24% of these 45 that 
could probably have been detected by an additional 
annual mammographie screening 
2. Those seven cases that were radiologically occult 
even at diagnosis but were palpated by the patient her­
self suggest that the number of these interval cancers 
could very probably have been reduced by the addition 
of routine physical examination It is not clear what 
contribution this would make to reduction of mortality 
Data of the Health Insurance Plan of Greater New 
York, for example, showed clearly, however, that the 
benefit of screening was partly due to phvsical exami­
nation 9 
Table 7 gives an overview of the reasons for missed 
detection of the 64 interval cancers on screening mam­
mogram About one third of the tumors were probably 
loo small al screening ("real" interval cancers) This 
group indicates that the two-year interval between 
screenings is probably longer than the optimal interval, 
at least for the population involved in this study About 
another third of the tumors were probably large enough 
but still camouflaged b> a dense breast and/or by a 
diffuse tumor mass or by fully intraductal tumor lo­
calization without signs of microcalcifications From 
these data, it seems that women with dense breasts 
should be screened aggressively that is, more frequently 
by using more views and modalities such as xerora­
diograph y and physical examination and with broader 
criteria for advising surgical biopsy l 0 
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Mammographically Occult Breast Cancer 
A Pathologic and Radiologic Study 
ROLAND HOLLAND, MD,* JAN H C L HENDRIKS M D . f A N D M A R C E L M R A V U N A C , ΜΟ,φ 
Fifteen mammographirall} occult breast cancers, 3 of which were preinvasive and 12 invasive, and 52 
breast cancers, which presented only microcaleifìcations mammographically without an associated tumor 
shadow (33 preinvasive and 19 invasive), were reviewed pathologically and radiologically. This stud} 
suggests that most of the preinvasive cancers, without mammographically significant calcifications, are, 
and some of the invasive cancers situated in dense breasts ma> be, mammographicall) occult. The mean 
diameter of the five mammographically occult invasive ductal carcinomas and the five invasive lobular 
carcinomas was 20 mm and 50 mm, respective!). Histologic characteristics, which ma) explain why 
invasive lobular carcinomas could be occult mammographically, even in an advanced stage, include a 
diffuse invasive pattern and, frequently, a poor desmoplastic reaction in contrast to the invasive ductal 
carcinomas. The implications of mammographically occult cancers on management of symptomatic and 
asymptomatic patients are discussed 
Cancer 52 1810-1019, 1983. 
Т
нь SENSITIVITY of mammography in detecting cancer 
in symptomatic palients ranges from 81% to 96%, 
according to relatively recent publications (Table 1) Of 
the 4% to 19% fai se-negati ve mammograms, at least 50% 
prove to be erroneous mammographie diagnoses on re­
view This problem may be prevented by following a 
number of strict rules This group of misdiagnoses has 
been thoroughly analyzed in a number of papers, and 
such rules are well established ' ' The other part of the 
false-negative diagnoses covers a group of cancers which 
are truly mammographically occult, ; e. they cannot be 
recognized on the mammogram even in retrospect These 
tumors do not produce significant mammographie signs 
These false negatives are considered as the inherent errore 
of the diagnostic method In part because these errore 
are virtually unavoidable, less attention has been paid so 
far in the literature to the group of radiologically occult 
cancers They constitute about 2% to 9% of the tumore 
of symptomatic patients (Table I) In addition, they may 
play an important role in the production of sensitivity 
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errors in screening mammographie examination of 
asymptomatic women, and thus in limiting the effec­
tiveness of mammographie screening programs m general. 
The current report deals with the pathology of the 
mammographically occult cancere and analyzes thetr 
consequences in both symptomatic and asymptomatic 
patients 
Materials and Methods 
The study is based on two different sources of material. 
Fifleen patients with mammographically occult cancere 
comprised the first group, 10 were discovered within a 
population-based mammographie screening program of 
the city of Nijmegen, the Netherlands, and 5 were dis­
covered outside this population All patients were treated 
in the two hospitals in Nijmegen between 1975 and 1980 
Seven of those 10 within the screening population were 
so-called interval cancere (cancers discovered between 2 
screening examinations, after a previous screening which 
was considered negative) and 3 were found among the 
nonrespondent patients (Table 2) We selected these 15 
cases as follows as a fi ret step, false-negative mammo­
grams were identified, and defined as cases in which a 
mammographie report shortly before operation for cancer 
did not reveal any changes that were suspicious for ma­
lignancy All of these false-negative mammograms were 
then reviewed with the knowledge of the location and 
extension of the cancer in the breast Based on this review, 
cases of observer error, misinterpretation (benign versus 
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malignant), poor positioning, or other poor techniques, 
were eliminated Cases were also excluded in which (he 
companson of the preoperative mammogram with a pre-
vious one led to the recognition of a developing or in-
creasing density After this selection process, there re-
mained the 15 cancere which were regarded as mam-
mographically occult, t e, they did not present any direct 
or indirect radiologic signs of tumor It should be em-
phasized that all these patients visited their physicians 
with breast complaints of a palpable mass, pain, nipple 
discharge, or areolar skin changes X-ray photos, including 
specimen radiograms, and histologic slides from each pa-
tient, were reviewed to identify reasons for the lack of 
mammographie changes 
The second source of materia) used consisted of 52 
cancers from the screening program in which significant 
calcifications were the only mammographie changes 
These cancere showed no associated tumor shadow or 
area of disturbed architecture, and 45 of them were clin-
ically silent It is known that about 50% of all breast 
cancere do not produce mammographically significant 
calcifications4 Since truly occult cancers are by definition 
not accessible to study, we included this group of 52 
cancere with calcifications as the only significant mam-
mographie change, in an attempt to draw indirect con-
clusions about cancers with similar biologic charac ten sties 
but without such calcifications Thus in an attempt to 
learn something about truly occult cancers, this group of 
52 cancers of which 45 were clinically silent, is comple-
mentary to the group of 15 cancere desenbed above which 
were symptomatic, but totally silent radiographically 
Mastectomy specimens of patients with breast cancer 
operated on in both hospitals of Nijmegen were examined 
in one laboratory by correlative specimen radiography 
and by histologic techniques Through these methods the 
masteclamy specimen was macroscopically sectioned at 
5 mm to 6 mm Each macrosection was x-rayed and 
histologic slides were taken from both the grossly and 
the radiological I y suspicious areas The main purpose of 
this method was to investigate the multifocality of the 
tumors In a number of these cases, tumor foci were seen 
grossly and/or microscopically, which did not present 
radiologic changes, either on the specimen radiogram or 
on the preoperative mammogram Examples of these cases 
are shown in the figures A thorough analysis of this ma-
terial, however, is beyond the scope of this article and 
will be presented elsewhere 
The mammograms were performed on a Senographe 
unit (Compagnie Générale de Radiologie, Pans) using 
Kodak Min-R screen and film Each patient had at least 
two views, a craniocaudal and an oblique view In some 
cases magnification views were also performed 
The density of the breasts was recorded according to 
Wolfe's classification 5 
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Results 
Table 2 shows selected charactenstics of the 15 mam­
mographically occult cancers and Table 3 shows selected 
characteristics of those 52 cancers which presented only 
imcrocalcifìcations without an associated tumor shadow 
by mammography The findings will be discussed by his-
topathologic tumor type 
Invasive Duaal Carcinoma 
Five of the 15 mammographically occult cases were 
invasive ductal carcinomas (IDC) Three of these tumors 
were situated in prominent duct pattern (P2) and two in 
dysplasia (DY) breasts (mean diameter, 20 mm) Of those 
52 tumors with mammographie calcifications without as-
sociated tumor mass, 7 proved histologically to be invasive 
ductal carcinoma (mean diameter, 12 mm) Five tumors 
were found in P2 or DY. and 2 in PI breasts Without 
the microcalciftcations, all of these cancers would have 
been mammographically occult Invasive ductal carci-
nomas are mostly associated with strong desmoplastic 
reaction, but if the tumor is embedded in dense fibro-
glandular tissue, the difference in densit) may not be 
enough to be appreciated mammographically as a focal 
mass In some of these cases, echographic examination 
may discover the tumor (Fig 1) These tumors may be-
come mammographically manifest by developing micro-
calcifìcations, or by extending into fat While the tumor 
extending into fatty tissue will then be recognized the 
rest of the tumor, embedded in fibrous tissue, will remain 
mammographically hidden This may explain the sub-
stantial differences in tumor size sometimes reported by 
the radiologist and the pathologist for the same tumor 
situated in dense breast 
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TABLE 2 Sdeclcd Charactenstics of Mammographitally Occult Cancers 
Croups and patient no 
Interval caneen 
1 
2 
3 
4 
5 
6 
7 
Caneen in nonrespondents 
β 
9 
10 
Cancers discovered outside 
screening 
Π 
12 
13 
14 
IS 
Histologic type 
DCIS 
ILC 
ILC 
ILC 
IDC 
IDC 
IDC 
DCIS + M 
ILC 
IDC 
DCIS + M 
Paget 
Paget 
DCIS + micToinvasion 
<5 mm 
LC1S 
ILC 
IDC 
Tu φ in mm 
pathology* 
20 
30 
80 
60 
22 
20 
30 
ι 
90 
11 
20 
10 
ч 
10 
20 
Results of clinical enamination 
Mastopathy dubious tenderness 
Suspicious tumor φ 1S mm 
Suspicious tumor φ 20 mm 
Mastopathy dubious nodulamy 
Benign nodule 
Mastopathy dubious lendemess 
Suspicious tenderness φ 80 mm 
M Paget 
Nipple discharge suspicious tu 
Φ IS mm 
Suspicious tumor Φ IS mm 
M Paget 
Benign nodule cyst7 
Mastopathy dubious tendemess 
Tenderness φ 60 mm lipoma7 
Benign resislencv 
Breast pattern 
by Wolfe' 
DY 
P2 
P2 
DY 
DY 
P2 
P2 
P2 
P2 
P2 
N1 
P2 
P2 
PI 
DY 
DCIS ductal carcinoma ш snu IDC invasive ductal carcinoma 
LOS lobular carcinoma in utu ILC invasive lobular carcinoma 
* In cases of in snu canLcrs the diameter is given of the area wilhm 
which foci of tumor could be seen 
Invasive Lobular Carcinoma 
Five of the 15 mammographically occult cases were 
invasive lobular carcinomas (ILC) All but one of these 
were situated in P2 or DY breast The one tumor in PI 
breast measured 10 mm and was located in a partly fi­
brosed lipoma The mean size of the tumore in dense 
breast was 65 mm In one multifocal ILC situated in PI 
breast the only significant mammographie sign was cal­
cification m an area with a diameter of 40 mm Without 
the calcifications, this cancer would have been mam­
mographically occult Invasive lobular carcinoma in dense 
breast can attain a size of several centimetere and may 
still lack mammographie signs, making this tumor one 
of the most frustrating mammographically occult invasive 
cancere (Fig 2) Some of the histologic charactenstics of 
the tumor may provide an explanation for this phenom­
enon ILC m general shows a diffuse invasive pattern, 
ƒ e the tumor cells are rather evenly spread throughout 
the fibrous or fatty tissue The fibrous tissue which ac­
companies the single tumor cells or the tumor cells in 
small groups is. in contrast to the IDC, frequently of a 
loose type, containing relatively few mature collagen fibers 
and relatively more reticulm (Fig 2B and Fig. 3) Thus, 
this connective tissue is very much like the specialized 
loose fibrous tissue of the normal lobule, correlai ι ng well 
TABI E 3 Selected Charactenstics of Breast Cancers With Calci fu. aliens but Without Associated Tumor Mass on Mammogram 
Type of cancer 
DCIS4 
DCIS -f microinvasion <S mm 
IDC 
ILCII 
Total 
No of cases 
33 
I I 
7 
1 
52 
Approsimate 
diameter of 
tumor in 
Mean 
27 
31 
12 
40 
27 
mm" 
Range 
5-100 
6-80 
8-20 
5-100 
N1 
2 
— 
— 
— 
2 
distribution of cases 
breast patternt 
PI 
17 
4 
2 
1 
24 
P2 
9 
7 
1 
— 
19 
by 
DY 
5 
— 2 
— 
7 
Not 
Palpability 
palpable 
28 
10 
6 
1 
45 
no» 
Palpable 
5 
— I 
6 
DCIS duaal carcinoma in situ IDC invasive ductal carcinoma 
LCIS lobular carcinoma in situ ILC invasive lobular carcinoma 
* In cases of DCIS vu ih or without associated invasion the diameter 
is given of the area within which fou of tumor could be seen 
t Breast pattern bv Wolfe s classification ' 
X Could not be ret π ved from the records in one case of DCIS with 
microinvasion 
§ One case m association with Paget s disease 
| Six invasive foci of 3 to 10 mm as a total area of 40 mm diameter 
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/ 
/ 
ч 
FIGS IA-1С (A. top left) Mammographically occult invasive ductal carcinoma φ 15 mm in the outer lower quadrant In both outer quadrants. 
within the indicated field (?) 13 foci of mammographicalh occult intraductal carcinoma were found by correlated specimen radiographic and 
histologic examination (B bottom) Specimen radiogram ofa 5 mm slice of the breast Multiple foci uf intraductal carcinoma were seen histologically 
around the area of the biopsy defect in ñelds К. L. Μ. Ρ and Q. where there were no suspicious radiologic signs of tumor No calcifications were 
seen m the tumor radiologically or histologically (C. top nght) The invasive tumor focus was clearly seen on the echogram (T). while the preinvasive 
foci remained occult 
with the assumption that this invasive tumor arises in 
the lobular-terminal duct unit Correlated specimen ra­
diography and histopathologic examination showed that 
areas with this specialized fibrous stroma of the tumor 
produce little or no change in density, and. thus, may 
not be appreciated as a localized density mammograph-
ically. especially in dense breasts Another characteristic 
of the ILC is the poor outline of the tumor mass, which 
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Fies ЗА ASD 2B {A. left) Mammographicallv occult invasive lobular carcinoma in the nghl (R) breast (I) extension of tumor according to 
correlated specimen radiographic and histologic examination ( 9 x 3 x 3 cm) Notice that there is no obvious mammographie asymmetry between 
the two breasts (B, right) An area of the invasive lobular carcinoma with poor desmoplastic reaction containing mainly reticulin fibers (Azan, 
original magnification X80) 
also renders its mammographie recognition difficult- This 
tumor ma> become manifest radiological I y in a dense 
breast b\ calcifications, by secondary signs such as nipple 
retraction, or by an increasing density recognized mostly 
in relatively advanced stages of tumor growth 
Duaal carcinoma in situ 
In four of the mammographicallv occult cases, the 
dominant histologic type was ductal carcinoma m situ 
FIG 3 Invasive ductal carcinoma with strong desmoplastic reaction 
containing mainly mature collagen (Azan. original magniñcation x80) 
(DCIS). In addition to the intraductal tumor, in two cases 
Paget's disease was observed and in one case microin-
vasion was seen. The size of the region where tumor foci 
could be detected was 20 mm or less. One of the tumors 
was situated in a normal (N)l breast, the others m P2 or 
DY breasts. Among the 52 cancers with mammographie 
microcalcifications without associated tumor mass. 44 
(84%) had a dominant histologic type of DCIS, 11 of 
which showed microinvasion. In 23 cases (52%), the tumor 
was situated in N1 or PI breasts with a maximum ex-
tension of 100 mm. These 44 cancers would have also 
been mammographically occult without the calcifications. 
Most of the intraductal carcinomas will remain mam-
mographically occult if microcalcifications are absent in 
the tumor, and may become radiologically manifest by 
development of microcalcifications, by indirect signs such 
as nipple retraction, or asymmetry in an advanced stage. 
or by becoming invasive (Fig, 1 and Fig. 4). 
Lobular carcinoma in situ 
Only one of the 15 mammographically occult cancers 
were histologically defined as lobular carcinoma m silu 
(LCIS)- A senes of specimen radiograms of foci of LCIS 
associated with an invasive carcinoma but remote from 
the invasive mass showed that this tumor does not present 
mammographically significant changes even in transpar-
ent breasts (Fig- 5). 
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FIGS 4 A AND 4B Widespread foci of intra-
duclal carcinoma in both lower quadrants (9 
x 4 x 3 cm) (A. top) Except for the focus with 
calcihcations {φ 10 mm) the tumor was mam-
mographically occult (Î) held of tumor exten-
sion according to specimen radiographic and 
histologic examinations (D. bottom) Specimen 
radiogram of the tissue slices of the biopsy (I) 
tumor focus with calcifications In addition to 
this focus, there were multiple tumor foci his-
tologically in all tissue samples of the totally 
embedded biopsy, where no suspicious radio-
logic signs were seen. 
Discussion 
The problem of the mammographically occult cancer 
begins with its definition One common definition is that 
these are cancers without recognizable direct or indirect 
mammographie signs This definition conceals a number 
of subjective factors, which make comparison of data 
between different diagnostic centers rather difficult As-
suming that state-of-the-art mammographie technique is 
used, the accuracy of the method is still highly dependent 
on the expenence of both the technician and the radiol-
ogist. Rates of false negatives in a screening project may 
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FIGS SA A N D 5B (A. top) Mammographically positive invasive 
ductal carcinoma φ 20 mm in the outer lower quadrant Π) Within 
the indicated held (I). 12 foci of mammographically occult lobular 
carcinoma in чііи (LOS) were found disseminated in all quadrants 
of the breast, according to specimen radiographic and histologic 
examinations In 2 of these 12 foci, in addition to LCIS. there were 
also intraductal localizations (B, bottom) Specimen radiogram of 
the two 5 mm thick slices of the breast In fields С D. and E, where 
there were no radiological!у suspicious changes, multiple foci of 
preinvasive carcinoma were seen histologically 
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be reduced by almost 50% if three experienced radiologists 
read the films instead of one * The number of cases ap­
parently occult on initial reading can be substantially 
reduced on review of the Alms if the site of the tumor 
is known Other factors influencing accuracy are the 
number of views and magnification views applied per 
patient We expenenced in periodic screening the great 
importance of having a previous mammogram for com-
panson in order to detect microcalcihcations or suspicious 
densities, either developing or increasing For this reason 
studies of symptomatic patients from which previous 
mammograms are frequentlv not available for compar­
ison may report a relatnely high number of radiologicallv 
occult cases One has to bear in mind all these factors 
when considering the wide vanance in rates of mam-
mographically false-negative and occult cancers given by 
different studies 
Imasne Cancers 
A number of studies have emphasized the observation 
that dense breast is the most important obstacle in mam­
mographie diagnosis and thus the source of a number 
of false-negative diagnoses ' * ^ ч The threshold size of ra-
diologically detectable invasive breast cancer in trans­
parent breasts is about 5 mm according to most inves­
tigators whereas cancers in dense breasts may grow to a 
size of 20 mm to 30 mm and still remain occult mam-
mographically if they are embedded in dense fibroglan-
dular tissue The difference in density between the fibrous 
stroma produced by the tumor mass and the surrounding 
fibroglandular tissue may not be enough to be recognized 
radiologically This problem is seen even with the well 
outlined discreet tumor mass of an IDC with well-de­
veloped desmoplastic reaction 
Tumors of diffuse invasive type with poorly outlined 
tumor mass, such as those seen with most ILCs present 
an additional diagnostic problem These tumors usually 
produce poor desmoplastic reaction The fibrous tissue 
in which the tumor cells are embedded is often of a loose 
edematous type which does not manifest increased density 
radiologically This is probably the reason why ILCs mav 
be missed radiologicallv even with a size of several cen­
timeters Unfortunately the accuracy of physical exam­
ination of this tumor is also poor Table 2 shows that in 
three of the mammographically occult ILCs with sizes of 
30 80 and 90 mm onlv a part of each tumor (15 20, 
and 15 mm, respectivelv) was palpable In an additional 
two cases, no definite tumor could be palpated The study 
of interval cancers in our screening project showed that 
the mean size of cancers when discovered by the patient 
was more than twice as large in cancers with a poorly 
outlined diffuse invasive type of tumor mass (mainly 
ILC) in com pan son with cancers with a better outlined, 
lump type tumor mass (mainly IDC), 49 mm and 23 
mm, respectively I 0 
Noninvasive Cancers 
Some studies have reported radiologic signs of intra­
ductal cancer in addition to calcification" I3, among these 
are focal density based on pendu eta I fibrosis and localized 
ductal ectasia We believe that DCIS with such radiologic 
signs is an exception Among our 234 screening cancers 
only one intraductal cancer was discovered on the basis 
of mammographie signs other than microcalcifications 
This intraductal cancer was found as an incidental finding 
adjacent to a fibroadenoma Focal density may be seen 
in a transparent breast if the tumorous ducts are con­
centrated in a limited area where the periductal fibrous 
tissue may merge to form a focal mass Ductal ectasia is 
a nonspecific sign of intraductal carcinoma We believe 
that from a practical point of view intraductal carcinomas 
without significant mammographie calcification should 
be regarded as radiologically occult Some of these in­
traductal cancers may eventually be recognized if calci­
fications develop or in a more advanced stage by asym-
metrv, by nipple retraction or by other secondary signs 
In situ lobular carcinoma is usually an incidental find­
ing since it has no specific clinical or radiologic signs 
Calcifications reported in association with some of these 
tumors were found on histologic examination often in 
both the tumorous and nontumorous lobuli raising the 
question whether their presence was merely a cornei 
dencc ' 4 '* Associated palpable masses which frequentlv 
form the indication for biopsy are mostly histologically 
benign changes such as sclerosing adenosis focal cvstic 
disease or solitary cysts '* This tumor is usually occult 
radiologically irrespective of the pattern of the breast 
The most important consequence of the mammo­
graphically occult cancers is delayed diagnosis and treat­
ment due to the false-negative mammogram The pos­
sibilities of minimizing this delav are different in symp­
tomatic and asymptomatic patients To avoid such a delay 
in sxmpiomatu patients it is mandatory that physicians 
be aware of the existence of cancers which are difficult 
or impossible to recognize with the present radiologic 
methods A negative mammogram should never delay a 
biopsy which is already indicated on clinical grounds 
This recommendation was already made in 1966 by 
Wolfe | 7 one of the pioneers of modem breast radiology 
and has been repeated several limes in the past 15 years 
by a number of authors It is claimed that the radiologist's 
report should always state the grade of breast density and 
thereby the confidence level of the diagnosis 7 ι β 
Asymptomatic patients are those women who are par­
ticipating in a screening program or who are under pe­
riodic mammographie control because of nsk factors for 
breast cancer There is ample evidence that mammog­
raphy is presently the most effective method for detecting 
cancer in an early stage in the asymptomatic patient I V 2 0 
; e in a stage when curability is most likely 2 I There is 
hope emerging that periodic mammographie screening 
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can significantly reduce the mortality of breast cancer, 
which has remained substantially unchanged for many 
decades The existence of mammographically occult can­
cers is, however, very likely an important obstacle in 
achieving this goal 
One part of the radi о logicali y occult cases of screenees 
consisted of those few cancers which were discovered at 
screening, but by physical examination only Another. 
much more important manifestation of the radiologically 
occult tumors in screening programs, are those cancere 
which were missed at one mammographie examination, 
because they were at that time occult, and were discovered 
at the next examination or some time before it (screening 
cancers and interval cancers, respectively) If the interval 
between 2 examinations is short enough (about I year), 
then it is highly probable that many of the interval and 
screening cancere discovered in an advanced stage (>1 
cm diameter) were already present in a potentially de­
tectable size at the time of the preceding negative mam­
mographie examination, but were missed, either because 
of an error, or because they were radiologically occult10, 
exceptions may be a few very fast growing tumors 
There is of course no way to prove that such radio-
logically occult cancers were indeed present at the time 
of the negative screening mammogram Results of 
screening programs, however, provide sufficient circum­
stantial evidence for this For example, in a carefully 
organized breast cancer screening program,2" about 25% 
of the cancers detected at a second examination may be 
in a preinvasive phase and about one third may be so-
called minimal cancer (preinvasive cancere and invasive 
cancers with a size of <10 mm) These results clearly 
support the contention that mammography is the best 
presentlv available screening modality The same results 
can be approached, however, in another way One can 
ask Why is periodic mammographie screening not able 
to detect a much higher percentage of minimal cancers9 
In onlv a few cases will a high rate of growth provide an 
explanation for this, assuming that in such cases the length 
of time of the minimal phase is shorter than the 1-year 
interval between screenings In most cases, the duration 
ofthis minimal phase is presumed, on the basis of known 
distributions of tumor doubling limes,21 to be much longer 
than this screening interval Thus, these cancers had to 
be present in their minimal stage at the time of previous 
negative mammographie screening, but they were at that 
time very likelv still occult radiologically That is, they 
were in a preinvasive phase but lacked significant calci­
fications, or they were in an invasive phase but embedded 
in dense breast and, likewise, without calcifications 
There is good reason to assume thai invasive breast 
cancere develop from preinvasive intraductal or intra­
lobular cancers and that, at least in this stage, breast 
cancere are curable Screening programs would theoret­
ically show maximum benefit if all cancers were detected 
in their preinvasive phase There are at least two reasons 
which may explain wh> this has not been possible so far 
( I ) the high percentage of radiologically occult preinvasive 
cancere, and (2) the so-called length-biased sampling 
As pointed out above, most of the preinvasive cancere 
which lack radiologically significant calcifications are 
mammographically occult It is difficult to assess the 
percentage of these cancers among all preinvasive can­
cers Vanous studies put this figure between 15% and 
67% >33A2'' Some of these data are based on mammog­
raphy, others on histologic examination However, one 
has to realize that these cancere, if small, are occult both 
mammographically and clinically Thus, they are gen­
erally discovered as incidental findings, and collected senes 
of these tumore are almost certainly not fully represen­
tative 
There may be an indirect wa> to estimate the portion 
of preinvasive cancers with and without calcifications, 
/ e about 50% of all breast cancers show calcifications 
mammographically 4 24 As it is an exception that so-called 
pathologic calcifications (cancer-associated calcifications) 
disappear, but rather it is more likely that they grow 
during the course of tumor growth, we can assume that 
at least 50% of the preinvasive cancers do not contain 
radiologically detectable calcifications (This percentage 
is certainly a minimum, since calcifications may develop 
during the invasive course of the tumor ) Most of these 
cancers will probably remain undetected by mammo­
graphie screening in their preinvasive phase They may 
be detected dunng subsequent screenings in their early 
or advanced invasive course depending on the density of 
breast in which they are situated 
There is probably a significant difference in the length 
of preinvasive phase among the different breast cancere 
This is indicated b> examples of extensive intraductal 
cancers without invasive growth on the one hand, and 
small invasive cancers with very limited intraductal com­
ponent on the other hand Cancere with a short prein­
vasive phase are less likely to be delected in this stage by 
periodic examinations than those with a long preinvasive 
phase 
Through further improvement of the currently used 
radiologic methods, such as film-mammography, xero­
mammography, and echography, it should be possible to 
improve the diagnosis of breast cancers containing cal­
cifications and to differentiate more accurately among 
densities in dense breasts It can hardly be expected, how­
ever, that these methods would be able to delect prein­
vasive cancers that lack mammographie markere, such 
as calcification and fibrosis 
Unless this problem can be solved by introducing new 
diagnostic modalities, improvement in mammographie 
diagnostic accuracy will be limited to reducing the false-
negative cases (cancers apparently occult mammograph­
ically) to those in which the cancer is missed solely because 
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of the limitations of the radiologic method (real mam-
mographically occult cancers) 
The following recommendations may help to reduce 
false-negative mammograms to their theoretical 
minimum 
1. To state the grade of density of the breast and thereby 
the confidence level of diagnosis in each mammographie 
report 
2. To apply more views, including magnification views 
and other modalities, in addition to film-mammography, 
xeromammography, and echography in the diagnoses of 
dense breasts 
3 To keep in mind that physical examination is ca­
pable of finding some minimal cancers that are missed 
by mammography22 2b and. therefore, to consider physical 
examination as a screening modality adjunct to mam­
mography 
4 A so-called baseline mammogram performed some 
lime between ages 35 and 40 should be available for 
comparison, making diagnosis of symptomatic patients 
and first screenees more accurate 
5. Mammographie screening should be performed only 
with state-of-the-art technique and only by highly skilled 
and dedicated personnel 
Concerning these recommendations, one should keep 
in mind the inverse relationship between sensitivity and 
specificity of screening and diagnostic methods v Efforts 
to increase sensitivity slightly by intensifying the use of 
one modality (recommendations 2 and 4 above) or by 
introducing an additional modality (recommendations 2 
and 3, above) will decrease the specificity of the screening 
program and increase the cost, thereby reducing the cosi-
effecliveness of screening 
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ABSTRACT 
Six cases of mammary carcinoma with osteoclast-like 
giant cells are reported. In addition to the multinucleated 
giant cells and the prominent stromal angiogenesis reported 
in earlier reports, other characteristic features of the 
tumors were observed: 1. the gross appearance, characterized 
by a well-outlined lump-shaped dark brown tumor mass; 2. the 
round tumor shadow on the mammograms, originally interpreted 
as a cyst, a fibroadenoma or a medullary carcinoma; and 
3. the "adenocystic" pattern of the invasive tumor growth. 
The light and electron microscopic observations point to the 
intimate relationship between the tumor cell clusters and 
the giant cells and provide further support to the theory 
that these giant cells develop from mononuclear histiocytes 
in response to the production of some sort of extracellular 
material by the tumor cells. All of the 26 positive axillary 
nodes of three patients, and many intramammary lymphatics 
with tumor thrombi of two patients contained giant cells. 
These observations indicate that the benign giant cells 
comprise an integral part of the invasive tumor growth. The 
six cases were recognized in a series of 527 consecutive 
breast cancers, during a period of four years, in a popu-
lation of about 75,000 adult women. These data question the 
reported rarity of this distinctive variant of mammary 
carcinoma. 
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INTRODUCTION 
Up to the present time fifteen cases of a peculiar type 
of mammary carcinoma with osteoclast-like giant cells have 
been published. Four of these cases were reported more than 
40 years ago (1, 2, 3) and the rest in the last five years 
(4, 5, 6).. Three problems were repeatedly discussed in these 
previous reports: the origin of the multinucleated giant 
cells, as well as the significance of a second, seemingly 
characteristic feature, namely, the rich vascularity of the 
tumor. A further point of discussion was the biologic nature 
of these neoplasms. 
We have investigated six cases of mammary carcinoma 
with osteoclast-like giant cells in the last four years. 
These cases provide additional information about the pa-
thology, the mammographie image, and the biologic nature 
of this peculiar type of breast cancer. 
PATIENTS AND METHODS 
The six patients were all premenopausal women, 32 
to 55 years old (average, 43 years of age). Even the two 
middle-aged patients (54, and 55 years of age) had regular 
"menstruation" before the time of diagnosis. However, both 
of them were taking contraceptive hormones for several 
years. Five of the six patients were treated in the Uni-
versity Hospital of Nijmegen and one was treated in the 
other hospital of the city. There are approximately 130 
breast cancer patients treated in these two hospitals each 
year. The geographic region from which the six patients came 
(the city of Nijmegen and its suburbs) comprises approxi-
mately 75,000 women, 30 years of age and older. 
A preoperative mammogram was available in all cases. 
In all but one case, one or more previous mammograms were 
also available for comparison. All these mammograms were 
studied in retrospect. 
The biopsy and mastectomy specimens were sliced in 5 
to 6 mm intervals, and an average of 27 tissue samples were 
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taken per case for histologic examination (range, 15 to 52). 
In addition to the light microscopic examination, electron 
microscopic study was also carried out from glutaraldehyde 
and OsO.-fixed tumor samples from four patients. The thin 
sections were stained with uranyl acetate and lead citrate. 
The evaluation of breast cancer surgical specimens in our 
institute has been described in detail (7). 
Estrogen receptor (ER) and progesterone receptor (PgR) 
levels of the tumors were determined by the dextrancoated 
charcoal binding assay (8). Estrogen receptor and PgR 
levels were considered low when < 20 fmol/mg protein. 
RESULTS 
Table 1 contains the results in detail. 
All but one of the tumors were grossly well-outlined, 
deep brown in color and showed a well-circumscribed round 
shadow on the mammograms (Fig. 1). The size of the tumors 
ranged from 1.2 to 6 cm in diameter. There was no trend 
either in laterality or in the quadrants, outer or inner, 
involved by the primary (reference) tumor. 
Five of the six patients were treated by a Patey-mod-
ified radical mastectomy. Patient 3 was treated by simple 
mastectomy with incomplete removal of the axillary nodes 
because of positive apical nodes. 
All patients are alive of which four patients are free 
of disease and two patients have local recurrence. 
FIG. 1. Gross appearance of the tumor in the tissue sections 
of the biopsy of Case 2. A well-outlined lump with a diam-
eter of 6 cm. The cut surface of the tumor was dark brown. 
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Table 1. Selected characteristics of the patients and their tumors 
Gross characteristics 
Patient Age Site Size Margin 
No. (yr) (an) 
Color 
Microscopic characteristics 
Primary (reference) tumor 
Pattern of invasive grorth No. of mitoses 
per 400 turoor 
ce l l s 
1 55 RLIQ 2.5 
2 54 roOQ 6 
3 38 LUOQ 4 
4 39 UUOQ 2 
Circumscribed Dark brown 
Circumscribed Dark brown 
Moderately Yellow white 
circumscribed 
Circumscribed Dark brown 
.fidenocystic + solid-cribriform 0-1 
Menocystic + solid cribriform 0-1 
Solid cribriform + cord-like 2-3 
Adenocystic + solid-cribriform 2-3 
5 40 LUIQ 2.5 Circumscribed Brcwnish Menocystic + solid-cribriform 2-3 
6 32 HUOQ 1.2 Circumscribed Dark brown Menocystic + solid-cribriform 0-1 
Table 1. Oontinued 
Microscopic character is t ics 
Outside primary (reference) tumor 
In situ Involvement of Blunt duct No. of Ю З nodes. 
tumor lymphatics adenosis with giant cells 
/total no. of nodes 
ER/PgR Year of Follow-vp 
(fmol/mg- diagnosis status and 
protein) period (mo) 
lobular 
nene 
none 
lobular 
lobular 
lobular 
ductal 
0/22 
0/20 
14/14 
0/22 
2/29 
10/15 
8/663 
11/66 
0/146 
12/212 
39/211 
14/316 
1978 
1979 
1981 
1982 
1982 
1982 
MED (58) 
NED (48) 
Alive with 
recurrence 
Alive with 
recurrence 
NED (19) 
NED (13) 
local 
(26) 
local 
(20) 
αϊ 
ui 
RLIQ: right lower inner quadrant; RUOQî right upper outer quadrant; LUOQ: left upper outer quadrant; 
LUIQ: left upper inner quadrant; ER: estrogen receptor; PgR: progesterone receptor; NED: no evidence 
of disease; POS: positive; 1: All positive nodes contained giant cells; 2: ER and PgR levels were 
considered low when < 20 finol/mg protein; 3: In both breasts. 
HISTOLOGIC CHARACTERISTICS OF THE PRIMARY (REFERENCE) 
TUMOR 
In all but one case some areas of the invasive tumors 
showed distinctive architecture consisting of an "adeno-
cystic" pattern, that is, branching nests and clusters of 
tumor cells encircling numerous mucus-filled cystic spaces 
and enclosing lacunas of highly vascularized loose fibrous 
stroma (Fig. 2) . The content of the cysts gave positive 
reaction with both alelan blue and periodic acid-Schiff 
(PAS) stains. The tumor cells were uniform, with small round 
nuclei and unremarkable nucleoli. In general, there was no 
obvious cytologic pleomorphism seen. Fifty percent of the 
cases showed a low frequency of mitoses and 50% showed a 
moderate frequency of mitoses (0-1 and 2-3 mitoses per 400 
tumor cells, respectively). The biphasic cellular pattern 
characteristic of adenoid cystic carcinomas was absent. The 
highly vascularized loose fibrous stroma showed extensive 
hemorrhage of different ages. Areas with fibrosis and accu-
mulation of hemosiderin pigment pointed to old bleeding. 
FIG. 2. "Adenocystic" pattern of the invasive tumor growth 
with mucus-filled cystic spaces. Scattered multinucleated 
giant cells in the highly vascularized stroma (H & E, orig-
inal magnification xlOO). 
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In addition to the adenocystic pattern a more com-
pact growth with cribriform aspect and with less extensive 
stromal vascularization could also be seen in the invasive 
tumor foci (Fig. 3). In Case 3 this pattern of tumor growth 
was the dominant type. 
The presence of the numerous multinucleated osteoclast-
like giant cells was of course the most striking feature of 
these tumors. The giant cells histologically gave an obvious 
benign impression. They had up to forty nuclei with a ves-
icular appearance and with a prominent nucleolus. The cyto-
plasm was faintly basophilic and often contained numerous 
vacuoles. These cytologic features were clearly different 
from those of the tumor cells. On the other hand, there was 
an obvious similarity between the giant cells and the mono-
nuclear histiocytic cells situated extraluminally or in the 
stroma (Fig. 4). There were no metaplastic changes seen in 
the tumors, squamous, osseous, or cartiliginous. 
FIG. 3. A more compact invasive growth of the tumor with 
cribriform aspect. Notice the multinucleated giant cells, 
the mononuclear histiocytic cells, and the mucus in the lu-
minal spaces (PAS, original magnification x310). 
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There was a clear difference in the number of giant 
cells between the two growth patterns, that is, a signifi-
cantly higher concentration of giant cells was seen in the 
adenocystic tumor growth than in the more solid areas. The 
giant cells were present both within the duct-like cystic 
spaces ("intraluminal" giant cells) and in the stromal 
lacunas among the clusters of tumor cells ("extraluminal" 
giant cells). A highly distinctive feature was the intimate 
relationship between the tumor cell nests and the extra-
luminal giant cells lying outside the tumor clusters. These 
giant cells were usually situated in the immediate vicinity 
of, or almost attached to, the marginal tumor cell row of 
the cluster (Fig. 5). Sometimes this phenomenon was so 
pronounced that the giant cells formed a pseudocast of the 
tumor cell nests (Fig. 6). Another frequently observed 
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FIG. 5. Multinucleated giant cells in the immediate vicinity 
of the tumor cell clusters (H & E, original magnification 
x390). 
FIG. 6. A bizarre giant cell with pseudopodal process. 
Notice the close contact between the giant cell and the 
tumor cell clusters. The giant cell forms an imprint around 
the tumor cell nests. The slit-like spaces between stroma 
and tumor cell nests were regularly appearing artifacts 
(H & E, original magnification x310). 
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phenomenon was the opening of the epithelial boundary of the 
cystic spaces onto stroma which resulted in direct contact 
between the cystic lumina and stroma on the one hand and in 
a continuous transition of the lining secretory cells of the 
duct-like spaces into the encircling cell row of the tumor 
cell nests on the other hand (Figs. 7A and 7B). 
FIGS. 7A and 7B. The opening of ductal lumina (L) of the 
tumor onto the stroma. Notice the continuous transition of 
the lining secretory cells of the previous duct into the 
external cell row of the tumor cell nest (arrows) (H & E, 
original magnification x240). B. The same phenomenon on 
higher magnification. Penetration of loose stromal fibrous 
tissue into the original lumen. A giant cell is situated 
just in the opening. (Compare this Figure with the ultra-
structural observations of Fig. 13.) The slit-like spaces 
between stroma and tumor cell nests were regularly appearing 
artifacts (H & E, x500) . 
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It was frequently observed that the stroma was separated 
from the tumor cell nests by slit-like spaces. Although this 
feature should be interpreted as an artefact, it was a 
regular feature in these tumors. 
HISTOLOGIC CHANGES IN THE BREAST SPECIMENS OUTSIDE THE 
PRIMARY (REFERENCE) TUMOR 
In four of the six cases, foci of lobular carcinoma 
in situ were found in the mastectomy specimen. In the pa-
tient in Case 6 multiple foci of ductal and lobular car-
cinoma in situ were present in both breasts. 
A consistent feature in all cases was a type of blunt 
duct adenosis of variable severity. This could be charac-
terized as a prominent lobular hyperplasia with increased 
numbers of terminal ductules sometimes accompanied by in-
creased secretion. In some of the cases this process was so 
extensive that "giant adenomatous lobules" developed. 
Multiple intramammary lymphatics filled with tumor 
cells were seen in two cases. In many of the tumor thrombi, 
both osteoclast-like multinucleated giant cells and the 
cytologically similar mononuclear histiocytes could be 
traced. They were situated mostly in luminal spaces (Fig. 
8). 
NODAL STATUS 
In three cases, positive axillary nodes were found. 
They counted for a total number of 26. All of the positive 
nodes contained the multinucleated giant cells in their 
metastatic foci. In some of them the giant cells could 
easily be found mostly in those foci where the tumor growth 
maintained the adenocystic pattern of the primary tumor. 
The same areas showed marked stromal vascularity and large 
amounts of hemosiderin pigment as well. In some nodes with 
more compact tumor growth, the giant cells could be identi-
fied only in serial sections. 
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FIG. 8. Tumor thrombus with multinucleated giant cells and 
with mononuclear phagocytes (arrows) in an intramammary 
lymphatic vessel (H & E, original magnification x310). 
ELECTRON MICROSCOPIC FINDINGS 
The most striking ultrastructural feature of the multi-
nucleated giant cells was the abundance of cytoplasmic or-
ganelles; that is, the diffusely distributed large number of 
mitochondria and free polyribosomes, as well as the rough 
endoplasmic reticulum, which was situated often toward the 
periphery of the cell (Fig. 9). There were also numerous 
membrane-bound, lysosome-like electron-dense bodies scat-
tered throughout the cytoplasm. The nuclei were mostly 
irregular in shape with deep invaginations of the nuclear 
membrane. They contained one or two prominent nucleoli. The 
cell surface of the giant cells was covered by microvilli or 
by short, irregular cytoplasmic processes. The extent of the 
development of these microvilli differed according to whether 
the giant cell was situated in the luminal spaces or in the 
stroma. The intraluminal giant cells had mostly highly 
developed microvillous surface (Fig. 10), while the giant 
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FIG. 9. Electron micrograph of an "extraluminal" multinu­
cleated giant cell in close apposition to tumor cells in the 
upper right corner. The giant cell shows abundant cyto­
plasmic organelles (mitochondria, polyribosomes, lysosome-
like electron-dense bodies, and rough endoplasmic reticu­
lum), and nuclei with invaginations and prominent nucleoli. 
In contrast, the tumor cell shows a relative paucity of 
cytoplasmic organelles and unremarkable nucleolus (x5700). 
Inset: Interdigitating microvilli on the boundary of the 
giant cell (G) and the tumor cells (T). Notice the absence 
of a basal membrane (χΙΟ,ΟΟΟ). 
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FIG. 10. Electron micrograph of an "intraluminal" giant cell 
marked by highly developed microvillous cytoplasmic surface 
(xl5,600) . 
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FIG. 11. Two large mononuclear cells of histiocytic nature 
lying outside the lumina in the stroma of the tumor between 
myofibroblasts. Notice the ultrastructural similarity be-
tween these histiocytic cells and the giant cell of Fig. 9 
(x6200). 
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cells situated in the stroma around the tumor cell nests had 
less developed shorter microvilli. There was often an inter-
digitation between the microvilli of these "extraluminal" 
giant cells and the microvilli of the neighboring tumor 
cells indicating the close contact between the two types of 
cells (Fig. 9). 
There was an obvious similarity in the ultrastructure 
between the multinucleated giant cells and certain mono-
nuclear cells situated either intraluminally or in the 
stroma. These mononuclear cells also showed abundant cyto-
plasmic organelles, lysosomes, and irregular cytoplasmic 
borders with microvilli, reminiscent of the mononuclear 
histiocytes (Fig. 11). In contrast there was a significant 
difference between the ultrastructural features of the giant 
cells and the tumor cells. The tumor cells had relatively 
fewer cytoplasmic organelles, more regular nuclei, and 
unremarkable nucleoli. They were joined by desmosomal 
attachments (Fig. 12). In contrast to the observations of 
Factor and associates (5) there was no external basal 
membrane seen around the tumor cell nests, nor were 
extracellular luminal spaces observed surrounded by a basal 
membrane. Myoepithelial cells with intracytoplasmic fila-
ments were not observed among the tumor cells. The duct-
like spaces were lined by the microvilli of tumor cells and 
contained mostly amorphous material, erythrocytes, and 
often the mononuclear histiocytic cells or multinucleated 
giant cells described above. The opening of the ductal 
spaces onto the stroma has been observed electron micro-
scopically as well (Fig. 13). 
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FIG. 12. Electron micrograph of tumor cells lining a ductal 
space. The nuclei of these cells are uniform with unremark-
able nucleoli. There is a relative scarcity of cytoplasmic 
organelles. (Compare these cells with the giant cell in Fig. 
9.) Desmosomes and tight junctions are present (arrows) 
between the neoplastic cells (x7800). 
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FIG. 13. Opening of the lumen of a duct-like space lined by 
tumor cells, and containing erythrocytes as well as his-
tiocytic cells (x5200). 
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DISCUSSION 
PATHOLOGIC FEATURES 
Previous reports have concentrated mostly on two 
peculiar features of this special variant of mammary car-
cinoma, the multinucleated giant cells and the marked 
stromal angiogenesis (5, 6). In our series, most of the 
tumors appeared to have, in addition to these features, 
other distinctive characteristics regarding the gross 
pathologic appearance, the mammographie image, and a pe-
culiar type of invasive pattern. 
The well-outlined, dark brown, almost regularly 
round, tumor mass observed in five cases was so charac-
teristic that in four of the five cases the diagnosis of 
breast carcinoma with osteoclast-like giant cells was al-
ready suggested by this gross appearance. In our experience 
the only tumor with similar gross characteristics in the 
breast is a metastatic malignant melanoma. 
The same five tumors showed on the mammogram a well-
outlined round shadow which was interpreted in two cases as 
"probably cyst but solid tumor has to be ruled out", in one 
case as a fibroadenoma and in two cases as a medullary 
carcinoma. Only one of the six cases showed the more usual 
shadow with marginal spicules regularly seen in invasive 
ductal carcinomas. On review of previous mammograms in three 
cases, a cyst-like shadow was found in the same location as 
the tumor one, two, and six years before the operation 
(Cases 4, 6, and 1, respectively). Only one of these cysts 
was further evaluated (Case 6), namely, twice by aspiration. 
The cytologic examinations revealed clusters of epithelial 
cells without malignant features and multinucleated giant 
cells. It is difficult for us to assess the significance of 
these findings as we could not detect in any of these cases 
obvious histologic signs indicating a possible development 
of the tumor from a cyst. 
A further distinctive feature in five of the six cases 
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was the adenocystic pattern of invasive tumor growth. Al-
though similar to the histologic pattern of the salivary 
gland type adenoid cystic carcinoma of the breast, two 
features accepted as being diagnostic for this tumor were 
absent in our cases: (1) the extracellular cystic compart-
ments lined by a basal membrane; and (2) the participation 
of myoepithelial cells in the neoplastic proliferation 
(biphasic cellular feature; 9, 10, 11). The mucus-filled 
intercellular cystic spaces in our material were duct-
like, lined by tumor cells with cytoplasmic projections 
(apical snouts) and numerous microvilli on their luminal 
surface (Fig. 13). 
It was difficult for us to categorize these tumors in 
one of the two main groups of invasive breast cancers, 
namely, the ductal or lobular types. Based on the more 
compact areas of the invasive tumor growth with cribriform-
like pattern, some tumors seemed to suggest a ductal origin. 
On the other hand, the small, uniform cells in the same 
tumor growth, the scarcity of mitoses, and the cytologic 
similarity often noticed between the invasive tumor cells 
and those in foci of lobular in situ cancers suggested 
rather a lobular origin. Furthermore, in Case 3 an addi-
tional invasive pattern was seen with the classical features 
of a lobular carcinoma. The adenocystic pattern, however, 
which seemed to represent the most characteristic growth in 
our cases, does not fit comfortably in any of the well-known 
types of breast cancers. 
It is noteworthy, however, that Agnantis and Rosen (6) 
have not identified this adenocystic pattern of growth 
although in our cases it was so characteristic. There may be 
two explanations for this: (1) There are probably certain 
types of mammary carcinoma with osteoclast-like giant cells 
in which the adenocystic pattern is absent, as was the case 
in one tumor of our series; and (2) as most of their cases 
derived from retrospective studies, they were probably 
unable to examine all aspects of the tumors because of the 
limited samples available. 
70 
There is ample evidence for the development of benign 
multinucleated giant cells by fusion of mononuclear his-
tiocytes in different tumorous and granulomatous processes 
(12, 13, 14, 15, 16). Factor and associates (5) were able to 
demonstrate this form of development of the osteoclast-like 
giant cells in one of their two mammary carcinomas by elec-
tron microscopic study. These observations are also con-
firmed by our findings. Both light and electron microscopic 
studies showed an obvious similarity in the cytoplasmic and 
nuclear features of the giant cells and the mononuclear 
cells situated in the stroma and in luminal spaces of the 
tumor. 
The intimate association of the giant cells with the 
tumor cell groups and their relationship has been a puzzling 
feature of these tumors. That the formation of giant cells 
is probably induced by an antigenic stimulus related to the 
tumor cells was already suggested by Leroux (1) and dis-
cussed by others. It has been proposed that the tumor cells 
might elaborate some substances capable of eliciting giant 
cell formation and marked stromal angiogenesis (6). Some of 
our observations provide further support to this concept. 
1. The majority of the giant cells and the most pro-
nounced stromal angiogenesis was concentrated in the areas 
where the tumor showed the most extensive secretion, that 
is, in the adenocystic structures. 
2. Many of the giant cells and their probable precur-
sors, the mononuclear histiocytes, were situated in the 
luminal spaces where they were in direct contact with the 
secretion produced by the tumor cells. 
3. The opening of the cystic spaces onto the stroma 
made a direct contact possible between the secretory cells 
and the stroma, where tumor cells often maintained their 
villous surface without a delimitating basal membrane. These 
boundaries between cell nests and stroma were the places 
where giant cells regularly appeared. 
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The presence of these tumor-associated benign multi-
nucleated giant cells cannot be interpreted solely as a 
focal tumor-induced reactive process limited to the breast 
tissue. Agnantis and Rosen (6) reported two cases where the 
giant cells were also present in visceral metastases. In our 
three cases with axillary node involvement, all of the 
metastatic nodes contained the giant cells as well as the 
tumor thrombi in the intramammary lymphatics. These obser-
vations make it likely that the benign multinucleated giant 
cells constitute an integral part of the tumor and that the 
neoplastic tissue is capable of inducing them in any of the 
invasive foci, primary or metastatic. 
The steroid hormone receptor protein levels of the 
tumors in our series provide a further discriminating 
feature, since all but one tumor showed very low ER levels 
and all of the tumors had extremely high ratios between the 
ER and PgR levels (Table 1). Some authors have described an 
association between low tumor hormone-receptor protein 
levels and use of contraceptive hormones (17), whereas 
others deny this association even in patients who used the 
contraceptive until the time of operation (18). In our 
series, all patients took contraceptive hormones at some 
time in their lives; however, only three of them were still 
using the hormones at the time of diagnosis (Patients 1, 2, 
and 5). Patient 3 used the contraceptive until four months 
and Patients 4 and 6 until several years before mastectomy. 
CLINICAL FEATURES 
There are at least two clinical aspects which deserve 
special attention, i.e., the relatively young age of the 
patients and the relatively advanced stage of the disease 
when diagnosed. 
The average age of the patients in our series, 4 3 
years, is even lower than the average age of 49 years re-
ported in earlier series. Our youngest patient was 32 years 
old, while the youngest patient previously reported was 40 
years of age (5, 6). 
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The average size of the tumors (3 cm) and the high 
percentage of axillary node involvement at the time of 
diagnosis point to a relatively delayed diagnosis. This may 
be explained partly by the often benign mammographie ap-
pearance of the tumors. Our data on the stage of the tumors 
at diagnosis and the follow-up data reported by others (50% 
of the patients died of the disease) (6) does not indicate a 
favorable prognosis of this tumor compared with the usual 
types of invasive breast cancer. 
It is the general impression based on the cases re-
ported up to this time that mammary carcinoma with osteo-
clast-like giant cells is an especially rare type of breast 
cancer. Our series of six cases discovered during a period 
of four years among 527 consecutive breast cancers in a 
relatively small geographic area (within a population of 
about 75,000 adult women) seriously questions the apparent 
rarity of this tumor. The concentration of the cases in our 
material may be simply a tatter of chance, but it is also 
feasible that we are witnessing an unexplained increase of 
the incidence of this unusual type of breast cancer. 
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ABSTRACT 
Breast cancer multifocality was studied in mastectomy 
specimens by correlated specimen radiography and histologic 
techniques. The patients chosen for study were comparable to 
those eligible for breast conserving surgical therapy. Two 
study groups, one with 282 invasive cancers and the other 
with 32 intraductal cancers were selected from a group of 
399 consecutive cases by omitting patients who were clearly, 
or very probably not candidates for breast conserving sur­
gical therapy according to present trial criteria. Omitted 
patients included those with clinically and/or radiologi-
cally multifocal cancers and patients with tumor extension 
into the chest wall or skin (7%). Also excluded were the so-
called diffuse invasive cancers (θ%) , the clinically and 
radiologically occult tumors (3%) and the invasive cancers 
larger than 5 cm (3%). Of the 282 invasive cancers, 105 
(37%) showed no tumor foci in the mastectomy specimen around 
the reference mass. In 56 (20%) tumor foci were present 
within 2 cm and in 121 (4 3%) tumor was found more than 2 cm 
from the reference tumor. In 75 (27%) the tumor foci beyond 
2 cm were histologically noninvasive cancers and in 46 cases 
(16%) they contained invasive cancers as well. A comparison 
between the group with reference tumors less than 2 cm and 
the group with reference tumors more than 2 cm in size 
showed no significant difference between the groups in terms 
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of presence or absence of tumor foci, or distance of tumor 
foci from the reference tumor. If the 264 invasive cancers 
^4 cm in diameter of this series had been removed with a 
margin of 3 to 4 cm, 7% to 9% of the patients would have had 
invasive cancer left in the remaining breast tissue. Four to 
9% would have had foci of noninvasive cancer left in the 
remaining breast tissue. On the basis of the data on the 
distribution of tumor at different distances from the ref-
erence tumor, the present study estimates the expected rates 
of local recurrences following breast conserving surgical 
procedures relative to the extensiveness of the excision. 
The possible impact of post-operative local radiation 
therapy on the rates of expected local recurrence is dis-
cussed. 
INTRODUCTION 
Reported high rates of multifocality of breast cancer 
(about 40 to 60%) (1-6), based on pathologic studies, has 
been for many years a major deterrent to attempts to treat 
breast cancer with less mutilating surgical procedures than 
radical or total mastectomy. Nevertheless, a few non-ran-
domized studies were carried out which indicated that, in 
selected groups of patients, the extensiveness of the local 
surgical therapy does not significantly alter rates of 
distant recurrence of disease or patient survival (7-13) . The 
results of the randomized controlled studies of Atkins et 
al. and Veronesi and associates comparing Halsted mastectomy 
with wide local excision or quadrantectomy supported these 
conclusions, at least for patient groups with TINO tumors 
(14,15). 
A significant finding of these studies was the rela-
tively low rate of local recurrence in the remaining breast 
tissue. This was in striking contrast to the high percentage 
of reported tumor multifocality in mastectomy specimens. 
This discrepancy may have several explanations. First of all 
the design of many pathologic studies did not parallel the 
design of the clinical studies. While the study groups of 
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the clinical trials for conservative surgical treatment 
generally comprised selected subsets of patients, most of 
the pathologic studies on multifocality were carried out on 
mastectomy specimens from consecutive patients, many of whom 
would not have met the eligibility criteria of the clinical 
trials. Another, recently cited observation is that some of 
the clinically occult lesions which are histologically 
considered as cancers would probably not become clinically 
significant during the life of the patient. Furthermore, 
post-operative radiation therapy, which is part of the 
design in many studies, is probably able to eradicate some 
of the tumor foci left behind after partial mastectomy (9, 
12, 13, 16). 
It is hoped that the carefully designed randomized 
studies now in progress, particularly those containing 
treatment arms with and without post-operative local radi-
ation therapy (17, 18, 19), will answer not only the ques-
tion whether or not conservation surgery as a treatment for 
breast cancer is justified but will also provide insight as 
to whether the histologically diagnosed multiple foci of 
cancers are biologically and/or clinically significant. Such 
an analysis must be based on a reliable estimate of the 
amount and type of tumor foci which are expected to remain 
in the breast after the various procedures of breast saving 
surgical treatment. These procedures often differ with 
respect to the extent of the excision and the size of the 
tumor considered eligible (see Table 1). 
The design of the present study on tumor multifocality 
in mastectomy specimens takes into account the designs of 
the various clinical trials by choosing subsets of patients 
comparable to patient-groups which would be clinically 
eligible for breast conserving surgical therapy (BCSTh). 
Thus the data from this study may provide an estimate of the 
amount and type of tumor foci which could be expected to 
remain in the breast following the various breast conserving 
surgical procedures. 
The study also attempts to analyze the effects of vary-
ing the eligibility criteria defining different allowable 
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TABLE 1. Craiparison of Eligibility Characteristics, Extent of Tumor Excision and use of Post-operative 
local Radiation Therapy of Some Randonized Clinical Trials for Breast Conserving Surgery. 
Tumor Size 
Nodal Status 
Extent of resection 
Intraductal cancer 
included 
Ineligible if margins 
of the removed segment 
are not tumor free 
Post-operative local 
radiation therapy 
(15) 
Milan-trial 
ΐ£ 2 an 
negative 
clinically 
entire breast 
quadrant 
no 
yes 
yes 
(19) 
Kopparberg-trial 
<2 cm 
negative 
histologically 
entire breast 
quadrant 
yes 
yes 
yes or no 
as two arms 
(17) 
NSAHP В-06-trial 
< 4 an 
negative or operable 
positive 
(18) 
ЕОКГС-10801-trial 
5 5 an 
negative or operable 
positive 
only which necessary only which necessary 
for grossly tumor free for grossly tumor free 
margins margins 
no 
yes 
yes or no 
as two arms 
yes 
no 
yes 
tumor sizes on the numbers of trial-eligible patients 
versus the percentage of expected local recurrence. 
MATERIALS AND METHODS 
The study population consisted of 413 mastectomy speci-
mens from 406 consecutive patients treated for breast cancer 
in the two hospitals of Nijmegen from 1980 through 1982. 
Three hundred and forty-three were routine surgical patients, 
while in 70 the tumor was discovered in a mammographically 
screened population. In 185 cases the mastectomy was per-
formed after a biopsy diagnosis and in 221 cases after a 
cytology diagnosis of cancer. In the remaining 7 cases the 
tumor was incidentally discovered by histologic examination 
of the contralateral breast removed for preventive reasons. 
All mastectomy specimens and most of the larger biop-
sies were examined in one laboratory with the correlated 
histologic and radiographic technique described earlier (20, 
21, 22) and known in the literature as the Egan's method. In 
this method the chilled specimens are macroscopically sec-
tioned at about 5 mm and a radiograph of each macrosection 
is made. Prior to sectioning, the gross specimens are 
oriented and their twelve and six o'clock point connected 
through the nipple with a superficial marking cut. Tissue 
blocks are taken from all of the grossly and radiologically 
suspicious areas in addition to some randomly selected ones, 
from each quadrant and the nipple. In general, the number of 
blocks taken paralleled the volume of the grossly indent-
ifiable glandular tissue. Thus the cases where relatively 
few slides were available were breasts with a predominance 
of fat tissue. Nevertheless, those 14 cases with less than 
10 blocks were eliminated from the study, leaving 399 cases 
with a total of 7979 blocks, an average of 20 blocks per 
breast specimen (range 10-62). 
The exact site of the tissue blocks taken, as well as 
the microscopically verified extension of a lesion within 
this field were indicated on the X-ray photos (Fig. 1A-D). 
The histologic type and size of the tumor foci were also 
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FIGS. 1. Α-D. Specimen X-rays of the breast slices (Α-C) and 
topographic diagram of the breast with frontal projection 
(D); Case Nr. 358. 
IDC, invasive ductal carcinoma; DCIS, ductal carcinoma in 
situ; LCIS, lobular carcinoma in situ; TUB, tubular car­
cinoma; LV, tumor in lymph vessels; UIQ, upper inner quad­
rant; UOQ, upper outer quadrant; ER, sample of tumor taken 
for determination of hormone receptor protein levels. 
Note the indicated fields in the X-rays which correspond 
with the tissue blocks where tumor foci were found on his­
tologic examination. The diagram shows the site of these 
foci and the distance between them. By these measurements 
the following reference points were used: (1) the breast 
slice with the largest cut surface of the nipple as the 
margin between the upper and lower quadrants, (2) the 
marking-cut at the 12 o'clock point on each slice indicating 
the border between the outer and inner quadrants and (3) the 
given thickness of approximately 5 mm of each gross tissue 
slice. 
In addition to the reference tumor (I), two invasive and 
some noninvasive foci were present in the breast. Only tumor 
(ΐ) was mammographically and clinically significant. 
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recorded on the X-rays next to each lesion. The distance 
between the margin of the reference tumor (the tumor which 
directed the biopsy or cytologic examination) and each of 
the other tumor foci was measured. For these measurements, 
the following points of reference on the radiograms were 
used: (1) the breast slice with the largest cut surface of 
the nipple as the margin between the upper and the lower 
quadrants, (2) the marking-cut at the 12 o'clock point on 
each slice indicating the border between the outer and inner 
quadrants, (3) the given thickness of approximately 5 mm of 
each gross slice. Estimated error in the distance measure-
ments could be about 15 mm or less. All data from each 
breast specimen were then transferred to a topographic 
diagram with a frontal projection and coded so as to be 
suitable for computer analysis. 
The histologic type and the distance of tumor foci 
within 2 cm of the reference tumor were defined but not 
analyzed further. Since in most breast conserving surgical 
procedures the reference tumor will be excised with a gross-
ly tumor free margin of at least 1 to 2 cm, these micro-
scopic foci will be removed with the reference tumor. 
Additional clinical and laboratory data for each pa-
tient are used in the present report to characterize the 
different groups rather than to analyze them as possible 
discriminants for the groups. Such an analysis will be 
presented as a separate study. 
RESULTS 
We first subdivided the total number of 399 cases in-
to different groups (Table 2) with the aim of separating 
those cases which clearly or very probably would not have 
been found eligible for BCSTh according to the criteria of 
the most generally accepted protocols (Table 1). 
Twenty-seven invasive cancers were clinically and/or 
mammographically multifocal or showed fixation to the chest-
wall or skin and were therefore excluded from the study. 
Thirty-one cases were histologically classified as 
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TABLE 2. Selected Groups of Cancers. Distribution of Cases. 
Groups of tvsrors 
Clinically/radiologically multifocal, 
or extension into the chest wall or skin 
So-called diffuse invasive cancers 
Invasive (non-diffuse) cancers 
0 > 5 an 
Clinically arc! radiologically occult 
Invasive (non-diffuse) cancers 282 (71) I 
0 < 5 on / 
1 Study group 
Noninvasive cancers 33 (8) ] 
ductal 32 
lobular 1 
315 (79) Subtotal 
399 (100) Ibtal 
so-called diffuse invasive cancers. These tumors, mainly 
lobular invasive carcinomas, consist of numerous, often 
microscopic tumor foci, distributed rather evenly in a large 
area which generally extends beyond the limits of a breast 
quadrant. The small foci are often separated from one an-
other by noneffected breast tissue, giving the tumor a 
multifocal aspect on pathologic examination. In the central 
part of the tumor, the foci may converge into the clinically 
or mammographically significant mass which is often only a 
small part of the whole lesion (23). Due to this often 
massive tumor extension, diffuse invasive cancers are in-
frequently treated according to BCSTh protocols. Tumor 
extension across the surgical borders of the excised breast 
segment often occurs and, on this basis alone, results in 
exclusion of this patient group from BCSTh programs. 
No (%) 
27 (7) \ 
31 (8) / Excluded fron 
V further analysis 
14 (3) I 
12 (3) / 
84 (21) Subtotal 
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Although not included in the study group deemed BCSTh-eli-
gible, the group of diffuse invasive carcinomas will be 
discussed separately. 
Fourteen cases of invasive, non-diffuse carcinomas 
were excluded from the study due to the histologically es­
tablished tumor size ( > 5 cm) which would be too large for 
treatment with BCSTh. 
Another 12 cases were excluded from this study as 
they were radiologically occult and clinically non-palpable 
(two invasive and ten noninvasive cancers) and therefore 
ineligible for BCSTh. They were discovered incidentally by a 
"blind" biopsy or by mastectomy for preventive reasons. 
Two groups of 282 invasive and 33 noninvasive cancers 
remained which were comparable with patient-groups eligible 
for BCSTh and thus suitable for analysis. 
INVASIVE CARCINOMAS, (NON-DIFFUSE), $5 cm, N = 2B2 
In studying the invasive cancers, selected character­
istics of which are shown in Table 3, it was hoped to de­
termine the type of tumor foci (invasive or noninvasive) 
present in the breast, apart from the reference tumor, and 
their distance from the reference tumor. In addition the 
study attempted to assess the effectiveness of incrementally 
increasing surgical margins in removing both reference tumor 
and additional tumor foci harbored in the surrounding tissue. 
Table 4 shows the proportion of cases in which no 
tumor foci were found (37%), and of those with foci within 2 
cm (20%), or outside 2 cm of the reference tumor (43%). This 
last group was further stratified according to whether the 
tumor foci were exclusively noninvasive carcinomas (27%) or 
partly to solely invasive cancers (16%). Sites of lymphatic 
emboli were regarded as invasive foci. The relative dis­
tribution of foci around the reference tumor seems inde­
pendent of reference tumor size. Chi-square analysis sup­
ports this observation; the difference between foci dis­
tribution patterns for reference tumors ^ 2 cm and those > 2 
cm was not significant (3 degrees of freedom, ρ > .50). 
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TABIE 3. Invasive (Non-diffuse) Cancers; 0 ^ 5 , Ν = 282: 
Selected Characteristics of the Patients and their Tumors 
ND (%) 
Age of patients 
<40 
40-60 
>60 
Тштог detected by screening 
yes 
no 
Dominant histologic type 
IDC 
ILC 
Other 
Status of axillary nodes 
Negative for tumor 
Positive for tunor 
Dissection not done 
31 
139 
112 
51 
231 
168 
47 
67 
149 
118 
15 
(11) 
(49) 
(40) 
(18) 
(82) 
(59) 
(17) 
(24) 
(53) 
(42) 
(5) 
Relation of clinical (CL), radiological (RA) 
and pathological (PA) tumor sizes, N = 230 : 
NO (%) CL<PA RA<PA 
CL > RA 93 (41) of which 2 23 
CL < RA 26 (11) of which 18 3 
^CL = RA 111 (48) of which 6 6 
"'RA = PA 77% 218/282 cases 
^CL = PA 52% 145/280 cases 
iTifty clinically or radiologically occult tumors and 2 cases where 
the clinical size was not available were excluded. 
Sizes which differed 5 шп or less were considered as being equal. 
In 2 out of the 282 cases the clinical size was not available. 
IDC = invasive ductal carcinoma; ILC = invasive lobular carcirona. 
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TABLE 4. Invasive (Non-diffuse) Cancers; Ν = 282: Distribution of Tumor Foci Versus Reference Tumor Size 
Reference tumor 
size 
No. of cases 
without tumor 
foci (%) 
No. of cases 
with tumor 
foci (%) 
Distance fron reference tumor 
Total 
^ 2 cm >2 an 
Noninvasive 
tumor foci 
Invctsive 
tumor foci 
«2 an 
^4 cm 
<5 an 
53 (41) 
101 (38) 
105 (37) 
22 (17) 
54 (21) 
56 (20) 
37 (28) 
71 (27) 
75 (27) 
18 (14) 
38 (14) 
46 (16) 
130 (100) 
264 (100) 
282 (100) 
Chi-square test on values for the group of tumors with sizes ^  2 an versus those 
with sizes > 2 an, three degrees of freedom, ρ > .50. 
Fig. 2 shows the distribution of tumor foci at differ­
ent distances from reference tumors of size ζ 2 cm: N = 130. 
This figure also indicates the relative effectiveness of 
incremental increases in tumor margin, at the time of ref­
erence tumor removal, in removing foci located at varying 
distances from the reference tumor. In other words, it shows 
the correlation between the width of margin around the 
reference tumor and the proportion of breasts in which there 
would still be tumor foci present beyond the given margin. A 
margin of 2 cm removes all tumor in breasts where either no 
tumor foci were present outside of the reference tumor or 
the tumor foci were within a distance of 2 cm, 75/130 or 58% 
in total. Of the remaining 55 cases, 37/130 or 28% would 
harbor solely noninvasive tumor foci and 18/130 or 14% 
invasive cancers as well. With a margin of 3 cm, these 
figures would drop to 9% and 8% respectively and at 4 cm to 
5% in both groups. This segment of breast tissue which would 
contain a tumor mass of ^ 2 cm and a margin of 4 cm around 
it would have a total size of 9-10 cm, which is on average 
the size of a whole breast quadrant. 
Figure 3 approaches the same problem in a slightly 
different way. The size of the breast segment containing 
both the reference tumor and the tumor foci is shown for 
each of the four different groups of tumors. It indicates 
the proportion of cases which would be cleared of tumor and 
the proportion which would still contain foci, in relation 
to breast segment size. In the subset of tumors with sizes 
$ 2 cm, a small biopsy of 2 to 3 cm would theoretically 
clear of tumor all breasts in which there were no tumor foci 
outside of the reference tumor, 41% in our study. If the 
size of the breast segment were 6 cm, an additional 22% of 
breasts would have become tumor-free, mainly those which did 
not contain tumor foci more than 2 cm from the reference 
tumor. A biopsy of 7 to 8 cm in size would increase the 
percentage of disease-free breasts to about 83, approxi­
mately 8% of the breasts would contain invasive tumor. The 
remaining 9% would contain only noninvasive foci. By re­
moving a segment of 9 to 10 cm, which approximates or, 
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FIGS. 2, 4, 5, 7. Distribution of tumor foci at different 
distances from the reference tumor and proportions of cases 
with and without tumor foci around the reference tumor. In 
Figs. 2 and 5 the pathologic size and in Figs. 4 and 7 the 
clinically estimated size of the tumors served as reference 
size. The latter means here the clinically or radiologically 
estimated tumor size. When different, the larger estimate 
was used as reference size. 
For each of the figures, the cases are divided into 4 
groups: 
A. Cases without tumor foci outside of the reference tumor. 
B. Cases with tumor foci within 2 cm of the reference tumor. 
The exact distance of these foci and their invasive or 
noninvasive character was not further specified. 
C. Cases with noninvasive tumor foci at a distance greater 
than 2 cm from the reference tumor. 
D. Cases with invasive tumor foci, at a distance greater 
than 2 cm from the reference tumor. 
The values of percentages within the groups indicate the 
proportion of cases with tumor foci located at or beyond 
the point given on the abscissa (distance from reference 
tumor). 
FIGS. 3 and 6. The size of the breast segment involved by 
both the reference tumor (pathologic size) and by the tumor 
foci around it. Proportions of cases with and without tumor 
foci around the reference tumor. For explanation of Α-D and 
values of percentages within the fields see legend of Figs. 
2, 4, 5, 7. 
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in some cases, exceeds the size of a whole breast quadrant 
these data would drop to about 5% in both groups. 
Obviously, prior to the operation only the clinical 
and mammographie estimates of the tumor are known and the 
pathologic size is not available. Therefore, we also studied 
the relationship between width around the reference tumor 
and the proportion of breasts with tumor foci beyond these 
margins, using only the mammographie and/or clinical esti-
mates of reference tumor sizes. We first analyzed which of 
the two estimates, the clinical or the mammographie, most 
closely approximates the "real" (pathologic) size of the 
tumor. This analysis showed that the percentage of mammo-
graphie estimates which were equal to pathologically-es-
tablished tumor sizes was significantly greater than that of 
the clinical estimates; 77% and 52%, respectively (Table 3). 
However, in the group of cases where the radiologically 
estimated size of the tumors was smaller than the clinically 
estimated size, a high proportion of the radiologic esti-
mates and only a small proportion of the clinical estimates 
were less than the pathologic size. The opposite was found 
when the clinical size was smaller than the radiologic size. 
In these cases, the clinical estimates were much more fre-
quently smaller than the pathologic estimates. This means 
that, in this series, if the clinical and mammographie sizes 
of a tumor were different, the larger of the two was more 
likely to be equal to or larger than the "real" (pathologic) 
size of the tumor. 
Figure 4 shows the effect of an increasing margin 
width around the tumor, when tumor size has been mammo-
graphically or clinically estimated, on the proportion of 
cases in which the remaining breast would be tumor free or 
would still harbor foci of cancer. When different, the 
larger estimate was used as reference size, thereafter 
called "diagnostic size". If one compares these data with 
the data using pathologic size as reference size (Fig. 2), 
some differences can be seen. The proportion of breasts with 
residual invasive foci outside a margin of 3 and 4 cm were 
11% and 9%, respectively, when the "diagnostic size" served 
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as reference size. When the pathologic size was used as the 
reference size these percentages were 8% and 5%. (See Figs. 
4 and 2). These differences are not significant. The dif-
ferences in the proportions of breasts with residual nonin-
vasive foci were statistically significant (p<.001) at both 
points (3 cm and 4 cm margins). As pointed out before, 
diagnostic reference measurements underestimate the patho-
logic sizes of tumors in certain instances. This was more 
likely to be so in cases having noninvasive foci of cancer 
around the reference tumor at a distance greater than 2 cm. 
The same sets of analyses which were performed on the 
group of cases with reference tumor sizes < 2 cm (Figs. 2-4) 
were also carried out on the groups with tumor sizes < 4 cm 
(Figs. 5-7) and on the total group (tumor sizes ^ 5 cm; 
(Table 4). There were no significant differences between the 
groups of tumors with sizes $ 2 cm and tumors with sizes 
> 2 cm, in the proportions of cases with and without tumor 
foci outside the reference tumor and in the distribution of 
these foci at different distances from the reference tumors. 
INTRADUCTAL CARCINOMAS, (N = 32) 
The size of an intraductal cancer was defined by the 
size of the area within which the intraductal tumor foci 
were distributed. As these foci are generally rather evenly 
distributed and have a similar histologic appearance, there 
is little justification, if any, to regard a limited group 
of foci as a primary reference tumor and the rest as se-
condary tumor foci. These lesions are often biopsied on the 
basis of a palpable lump, a group of mammographie calci-
fications and/or an area of "disturbed" architecture. How-
ever, in most cases the limits of these clinical lesions do 
not correspond with the pathologically-established tumor 
borders, in contrast to what is generally seen with the 
lumps and mammographie tumor shadows of invasive cancers, 
excepting some diffuse invasive cancers. If a biopsy con-
tains only a small albeit clinically significant portion of 
an extensive lesion, this will generally be determined by 
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pathologie examination of the margins, as the tumors tend to 
be evenly distributed, without large gaps between foci. In 
our series only one case was found with tumor foci located 
exclusively outside a 4 cm radius around the clinically 
identified tumor. For this reason, the series of intraductal 
cancers were analyzed for optimal segment size rather than 
optimal margin size, for the complete removal of tumor, 
leaving behind a disease-free breast. 
Table 5 shows the pathologic sizes of the tumors. 
About 40% of them were larger than 5 cm; these had a mean 
size of 9 cm (range 6-12 cm). About half of the tumors were 
4 cm or smaller and only about one third were 2 cm or less. 
Seventy-five percent of the cancers were non-palpable. 
In about two thirds of the tumors (21/32) the sole mammo­
graphie sign was suspicious microcalcification. When the 
area of these calcifications was compared with the pathologic 
extension of the tumors, θ of the 21 cases (38%) evinced a 
radiologic size which was less than the pathologic size; in 
all but one case this difference was greater than 2 cm. 
Further, in 38% (12/32) of all the tumors, the "diagnostic 
size" was similarly less than the pathologic size. 
DISCUSSION 
Currently, breast conserving surgery is rapidly gain­
ing ground in the Western countries due to growing demand 
for alternatives to mutilating surgery in treatment of 
breast cancer. The scientific and ethical bases for con­
tinuing this therapeutic modality, at least within carefully 
designed randomized trials, has already been provided by 
studies indicating that the results of breast conserving 
surgery followed by radiation therapy are not inferior to 
those of radical or total mastectomy, in terms of distant 
treatment failure and patient survival (7, 13, 15). However, 
there are still many problems which remain unsolved, pri­
marily concerning the local treatment failures, both in the 
short and long term. We know very little about the clini­
cally significant tumor which may remain in the breast after 
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TABLE 5. Selected Characteristics of the Group of Noninvasive Ductal Cancers, N = 32 
Size of No (%) Clinically Radiologically an area of Diagnostic size 
tumor (PA) not palpable microcalcificaticms only, 
of which the size 
«2 cm 
> 2 - 5 an 
> 5 an 
Total 
9 
10 
13 
32 
(28) 
(31) 
(41) 
(100) 
7 
7 
10 
24 
> PA 
3 
1 
9 
size5« 
21 
< PA size 
0 
5 
3 
J: PA size™ 
8 
3 
9 
32 
< PA size 
1 
7 
4 
PA = Pathologic; ^ Diagnostic size = clinically or radiologically estimated size, if different 
the larger of the two sizes. "Ίί sizes differed less than 5 nm they ware considered as being equal. 
the conservative treatment. We also do not know the rela-
tionship between the amount of residual tumor and the size 
of the reference tumor or of the breast segment with which 
the reference tumor is removed. Furthermore the effective-
ness of post-operative radiation therapy in preventing or 
delaying local recurrence has in general been satisfactorily 
documented (9, 12, 13, 16). However, it remains to be 
clarified whether radiation therapy is as effective on 
noninvasive residual tumor foci, which very likely con-
stitute the majority of the residual disease, as on occult 
invasive tumor foci. 
Randomized clinical trials of varying design are ex-
pected to contribute to the final answer of these questions. 
This is particularly true for those trials including treat-
ment arms with and without local radiation therapy; e.g. 
NSABP B-6- and the Kopparberg-trial (Table 1). 
Among the many pathologic studies on breast cancer 
multifocality were two studies concentrating on the prac-
tical surgical problems related to tumor multifocality. 
Rosen et al. studied the "residual" tumors which may remain 
in the mastectomy specimen after a simulated quadrantectomy 
and Lagios and associates examined mastectomy specimens for 
cancers with tumor foci found outside a 5 cm radius of the 
reference tumor, the hypothetical border of a breast quad-
rant. Rosen and associates reported residual tumor in 26% 
and 38% of the cases with reference tumors smaller than and 
greater than 2 cm, respectively (24). Lagios and colleagues 
found multifocality in 28% of studied cases (21). Both 
studies examined mastectomy specimens from consecutive 
patients. Such a group of patients is not directly com-
parable to those subsets of patients deemed clinically 
eligible for BCSTh. 
Consecutive cases frequently contain a number of so-
called diffuse invasive cancers. They comprised about 8% of 
our series and if included would have constituted about 30% 
of all cancers with invasive tumor foci outside a 2 cm 
radius of the reference tumor. These cancers are by defi-
nition pathologically multifocal as they consist of many 
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small tumor foci spreading over an area which is often 
larger than 5 cm (Table 6 ) . They are therefore clinically 
not relevant cases for BCSTh and if biopsied would be ex­
cluded from BCSTh consideration upon pathologic examination. 
The same is true for pathologically multifocal cancers in 
which the multifocality is preoperatively indicated, either 
by mammography or clinical examination. These cases are also 
encountered within a consecutive series but are, of course, 
equally ineligible. 
In the present study, a subset of cancers which were 
considered comparable with cases eligible for BCSTh were 
isolated from a consecutive series of breast cancers. Mul­
tifocality was then studied in the mastectomy specimens of 
these cases in an attempt to estimate the frequency with 
which tumor would remain in the breast after a breast con­
serving surgical intervention. All estimates were calculated 
relative to the size of the tumor and to the size of the 
breast segment removed. 
ТАБІЕ 6. Selected Characteristics of the Group of So-called 
Diffuse Invasive Cancers, N = 31. 
No of cases (%) 
Size of tuiror ^  5 an 
Pathologically 
Clinically 
Radiologically 
Histologic type 
ILC 
Other 
Tumor positive axillary 
nodes 
29X 
13 
7 
27 
4 
24 
(94) 
(42) 
(23) 
(87) 
(13) 
(77) 
ILC = Invasive lobular carcinoma, whether as the daninant type or 
as a conponent of the tumor. 
ïhree turrors only were 5 cm of diameter. 
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INVASIVE CANCERS 
If tumors measuring ^ 2 cm were removed with a margin 
of 4 cm, which is, on average, equal to a whole breast 
quadrant, about 5% of the cases would harbor invasive tumor 
foci in the remaining breast (Fig. 2). These foci could 
theoretically be the sources of short term recurrence. If 
those cases with multiple invasive foci falling within the 
theoretical excised quadrant around the reference tumor were 
excluded, the percentage of cases with invasive foci still 
remaining in the breast after BCSTh would drop to 2 to 3%. 
This frequency of expected recurrence closely approaches the 
rate of local recurrence reported after 8 years m the 
Milan-trial, which was 9/352 or 2.5% (25). In another 5% of 
the cases foci of noninvasive cancer would have remained in 
the breast after quadrantectomy. Such noninvasive tumor foci 
could be responsible for long-term recurrences. 
If the same series of tumors (^2 cm) were removed 
with only a limited margin of 2 cm, the following changes 
could be expected in the calculated rates of possible re-
currences. The expected short-term recurrences could in-
crease to 14% and the long-term recurrences to 28%, equal-
ling, respectively, the proportion of cases in which in-
vasive and noninvasive foci would have remained in the 
breast. It should be noted here that these percentages of 
cases still harboring invasive foci following excision with 
a margin of either 4 cm or 2 cm (5% and 14%, respectively) 
are not significantly influenced by the size of the tumor; 
e.g. whether ^ 2 cm or <4 cm in size (Figs. 2 and 5). A 
local recurrence rate of this order would be fairly accept-
able if one considers that recurrences after breast saving 
surgery can be treated by salvage surgery with reasonable 
success (11, 12, 26). In addition, these data would apply to 
treatment regimes with no post-operative radiation therapy. 
If local radiation therapy were able to eradicate most of 
the residual invasive and noninvasive foci, no significant 
difference m the rates of recurrence should be expected 
104 
following either limited or wide excision. If radiation 
therapy were not able to eradicate noninvasive cancers, the 
expected rate of recurrences, presumably long-term, would be 
significantly higher after a limited excision than after a 
total quadrantectomy. The analysis of an additional risk for 
developing "de novo" cancer in the remaining tumor-free 
breast tissue is beyond the scope of this study. 
It can be questioned on the basis of the results of 
the present study whether narrow patient eligibility cri-
teria (Milan- and Kopparberg-trials, Table 1) would indeed 
lead to significantly better results, compared to the trials 
with broader eligibility criteria (NSABP B-06- and EORTC-
trials). One can further question whether a limited excision 
is not equally as effective as a quadrantectomy if both 
procedures are followed by local radiation therpay. The 
present study indicates that if post-operative radiation 
therapy is capable of eradicating occult residual tumor 
foci, the trials applying broader patient eligibility cri-
teria and performing limited excision should result in 
response rates equal to those including more extensive 
excision. This is a rather important point as the estimated 
rate of patients potentially eligible for treatment in the 
trials with narrow criteria is about 25% of that in the 
trials with broader criteria. If radiation therapy is deemed 
insufficiently effective on residual invasive or noninvasive 
tumor foci, a wide excision would most likely be the optimal 
procedure in order both to reduce the number of cases with 
residual tumor to a minimum and to identify on pathologic 
examination those cases which could most efficiently be 
treated with total mastectomy; these would include cases 
with tumor foci outside a 2 cm radius of tumor, which could 
very likely harbor tumor foci at longer distances as well. 
INTRADUCTAL CANCERS 
Whether or not breast saving surgery is a justifiable 
treatment for intraductal cancer is still highly disputable. 
The principal argument against this type of treatment is 
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based on the fact that total mastectomy can cure intraductal 
cancer in almost 100% of the cases. However, more than half 
of these patients, if treated by simple biopsy, would like-
wise develop no significant invasive cancer during their 
lifetime (27, 28). For these patients, total mastectomy 
would be a highly mutilating overtreatment. A national 
survey by the American College of Surgeons (29) showed no 
significant differences in five-year cure and recurrence 
rates in patients with noninvasive ductal carcinoma treated 
either by radical surgery or wedge excision. 
Again, carefully designed clinical trials are needed to 
prove whether or not breast conserving surgery with or 
without post-operative local radiation therapy, or even 
radiotherapy alone, is an effective treatment for intraductal 
cancer. 
If intraductal cancer is to be treated with BCSTh 
there are several factors arguing against extensive excision 
techniques. These include the large proportion of these 
tumors which are widely spread in the breast at the time of 
diagnosis; in our series, 4 0% of the intraductal cancers 
were larger than 5 cm, with a mean size of 9 cm within this 
subgroup. Therefore even a quadrantectomy would not remove 
all foci. In addition the clinical estimates of these sizes 
are too inaccurate to be relied upon for surgery. In this 
series, 75% were clinically occult and the mammographie size 
of almost the half (46%) of the radiologically significant 
tumors was less than the pathologic size. Furthermore, the 
uncertain clinical significance of these tumors also argues 
against use of very large biopsies rather than smaller biop-
sies with more favourable cosmetic results. One argument 
which could be used to justify wide excision of intraductal 
cancers is the increased probability of revealing those 
cases which harbor occult invasive foci, about 6% according 
to the literature (30) and thereby to be able to treat the 
axillary nodes adequately. 
+ + + 
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By reporting tumor multifocality in the present study 
we have no intention of encouraging or discouraging surgeons 
to treat breast cancer by breast conserving surgery. As said 
before, only the results of randomized clinical trials will 
prove whether or not breast conserving surgery, with or 
without post-operative radiation therapy, is an acceptable 
alternative to radical or total mastectomy. 
What we do wish to indicate with this study is that 
the apparent discrepancy between the reported high per-
centage of breast cancer multifocality based on pathologic 
studies, and the reported low rate of local recurrences in 
the clinical trials for BCSTh, e.g. in the Milan-trial, may 
not be a discrepancy at all. When studying multifocality in 
mastectomy specimens from a subset of patients comparable to 
those patients considered clinically eligible for BCSTh, it 
became increasingly clear that the histologic pattern of 
multifocality combined with the type of resection employed 
in trials such as the Milan-trial, provided a very plausible 
explanation for the observed "discrepancy". 
In addition, the data presented here provide an es-
timate of the amount of invasive and noninvasive tumor which 
can be expected to remain in the breast tissue following 
the different types of breast conserving surgical procedures. 
They could thereby serve as reference data when evaluating 
the results of the clinical trials in general and the ef-
fects of post-operative local radiation therapy in particu-
lar. 
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SUMMARY 

The introduction of mass screening for breast cancer 
in Nijmegen created some new aspects in the clinical and 
pathologic diagnosis of breast lesions. About 40% of the 
cancers, discovered by the screening examinations in this 
project, had a size less than 1 cm, 60% were clinically 
occult and 30% were found solely on the basis of mammo-
graphie microcalcifications. The surgeon had to become 
accustomed to the excision of mammographically suspicious 
but clinically occult lesions. The pathologist had to learn 
to examine biopsies with mammographically suspicious but 
grossly invisible lesions. Furthermore, he had to become 
familiar with the so-called borderline lesions, since many 
of them happened to occur in the group of the clinically 
occult lesions. The method of the needle localization tech-
nique, followed by specimen radiography, was introduced to 
excise these clinically occult lesions. The specimen X-ray 
proved to be an excellent guide at the sampling of tissue 
blocks for histologic examination and at verifying the site 
of the lesions and their extent. The frozen section pro-
cedure appears to have only a limited role in the diagnosis 
of the lesions less than 5 mm and of those which were 
detected solely by mammographie microcalcifications. 
For the pathologic examination of mastectomy specimens, 
the so-called correlated histologic and radiographic tech-
nique was used. This method makes it possible to obtain 
detailed and reproducible data on the extension and site of 
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the various lesions in the breast and on their topographic 
relation to each other (Chapter 1). 
The topics of this dissertation were chosen on the 
basis of practical problems concerning breast cancer diag-
nosis and therapy. 
Chapter 2 comprises a pathologic and radiologic analy-
sis of 64 so-called interval cancers which were discovered 
between two consecutive screenings after one, two or three 
negative screening examinations. The study group consisted 
of 25.920 women who have been participating since 1975 in a 
breast cancer screening program in Nijmegen. In this 
program, a single view mammography (lateromedial projection) 
was administered as the sole screening examination every two 
years. Physical examination of the breast was not part of 
the screening program. 
All previous histologic and radiologic material from 
the 64 "interval" patients was reviewed. In 19 of the 64 
patients, direct or indirect signs of tumor were seen on the 
previous screening mammogram on review (observers error). In 
4 cases, the site of the tumor lay outside the imaging field 
(technical error). In 41 cases, no signs of tumor could be 
seen on the mammograms even on review. By calculated tumor 
doubling times, 20 of these 41 tumors were probably too 
small to be detected at the last screening ("real" interval 
cancers). However, 21 tumors were probably large enough but 
they were somehow masked from radiologic detection. The 
reason for this "masking" proved to be (1) dense breast, (2) 
poorly outlined tumor mass of diffuse infiltrative type, 
mainly invasive lobular carcinomas and (3) intraductal 
localization. 
We suggest that women with dense breasts be screened 
more frequently, using more views and modalities and broader 
criteria for advising surgical biopsy. It is also indicated 
that in general the two-year interval between screenings is 
probably longer than the optimal interval. 
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Chapter 3 includes a pathologic and radiologic study 
on mammographically occult breast cancers. The sensitivity 
of mammography in detecting cancer in symptomatic patients 
ranges from 81% to 96% according to relatively recent pub-
lications. Of the 4% to 9% false-negative mammograms, at 
least half prove to be based on erroneous mammographie 
diagnosis on review. The other part of the false-negative 
diagnoses covers a group of cancers which are truly mammo-
graphically occult, i.e., they cannot be recognized on the 
mammogram even on retrospect. These tumors do not produce 
significant mammographie signs. 
In this study 15 mammographically occult breast can-
cers, 3 of which were preinvasive and 12 invasive, and 52 
breast cancers, which presented only microcalcifications 
mammographically without an associated tumor shadow (33 
preinvasive and 19 invasive), were reviewed pathologically 
and radiologically. This study suggests that most of the 
preinvasive cancers without mammographically significant 
calcifications are, and some of the invasive cancers situ-
ated in dense breast may be, mammographically occult. The 
mean diameter of the 5 mammographically occult invasive 
ductal carcinomas and the 5 invasive lobular carcinomas was 
20 mm and 50 mm respectively. Histologic characteristics, 
which may explain why invasive lobular carcinomas could be 
occult mammographically, even in an advanced stage, include 
a diffuse invasive pattern and, frequently a poor desmo-
plastic reaction m contrast to the invasive ductal car-
cinomas. 
The most important consequence of the mammographically 
occult cancers is delayed diagnosis and treatment due to the 
false-negative mammogram. The study analyses the implica-
tions of these occult cancers on the management of sympto-
matic and asymptomatic patients. 
The following recommendations may help to reduce 
false-negative mammograms to their theoretical minimum: 
1. To state the grade of density of the breast and thereby 
the confidence level of diagnosis in each mammographie 
report. 
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2. To apply more views, including magnification views and 
other modalities in addition to film-mammography, xero-
mammography, and echography in the diagnosis of dense 
breasts. 
3. To keep in mind that physical examination is capable of 
finding some minimal cancers that are missed by mammo-
graphy, and, therefore, to consider physical examination 
as a screening modality adjunct to mammography. 
4. To obtain a so-called baseline mammogram some time be-
tween ages 35 and 40 that should be available later for 
comparison, making diagnosis of symptomatic patients and 
first screenees more accurate. 
5. To perform mammographie screening only with state-of-the-
art technique and only by highly skilled and dedicated 
personnel. 
In chapter 4 six cases of mammary carcinoma with osteo-
clast-like giant cells are reported. In addition to the 
multinucleated giant cells and the prominent stromal angio-
genesis reported in earlier papers, other characteristic 
features of the tumors were observed: 
1. The gross appearance, characterized by a well-outlined, 
lump-shaped, dark brown tumor mass. 
2. The round tumor shadow on the mammograms, originally 
interpreted as a cyst, a fibroadenoma, or a medullary 
carcinoma, and 
3. The "adenocystic" pattern of the invasive tumor growth. 
The light- and electron microscopic observations 
point to the intimate relationship between the tumor cell 
clusters and the giant cells and provide further support to 
the theory that these giant cells develop from mononuclear 
histiocytes in response to the production of some sort of 
extracellular material by the tumor cells. All of the 26 
positive axillary nodes of 3 patients, and many intramammary 
lymphatics with tumor thrombi of 2 patients, contained giant 
cells. These observations indicate that the benign giant 
cells comprise an integral part of the invasive tumor growth. 
The 6 cases were recognized in a series of 527 consecutive 
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breast cancers, during a period of 4 years, in a population 
of about 75.000 adult women. These data question the re-
ported rarity of this distinctive variant of mammary car-
cinoma. 
Chapter 5 deals with breast cancer multifocality stu-
died in mastectomy specimens by correlated specimen radio-
graphy and histologic techniques. The patients chosen for 
study were comparable to those eligible for breast con-
serving surgical therapy. Two study groups, one with 282 
invasive cancers and the other with 32 intraductal cancers, 
were selected from a group of 399 consecutive cases by 
omitting patients who were clearly not candidates for breast 
conserving surgical therapy according to present trial 
conditions. Omitted patients included those with clinically 
and/or radiologically multifocal cancers and patients with 
tumor extension into the chest wall or skin (7%) . Also 
excluded were the so-called diffuse invasive cancers (8%), 
the clinically and radiologically occult tumors (3%) , and 
the invasive cancers larger than 5 cm (3%) . Of the 282 
invasive cancers, 105 (37%) showed no tumor foci around the 
reference mass in the mastectomy specimen. In 56 (20%) tumor 
foci were present within 2 cm and in 121 (4 3%) tumor was 
found more than 2 cm from the reference tumor. In 75 cases 
(27%), the tumor foci beyond 2 cm were histologically nonin-
vasive cancers and in 46 (16%) they contained invasive 
cancers as well. 
A comparison between the group with reference tumors 
less than 2 cm and the group with reference tumors more than 
2 cm in size showed no significant difference between the 
groups in terms of presence or absence of tumor foci or 
distance of tumor foci from the reference tumor. If the 264 
invasive cancers < 4 cm in diameter had been removed with a 
margin of 3-4 cm, 7 to 9% of the patients would have had 
invasive cancer left in the remaining breast tissue. Another 
4 to 9% would have had foci of noninvasive cancer left. 
On the basis of the data on the distribution of tumor 
at different distances from the reference tumor, the study 
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estimates the expected rates of local recurrences following 
breast conserving surgical procedures relative to the ex-
tensiveness of the excision. The possible impact of post-
operative local radiotherapy on the rates of expected local 
recurrence is discussed. 
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SAMENVATTING 

De invoering van het bevolkingsonderzoek voor borst-
kanker in Nijmegen leverde enkele nieuwe gezichtspunten op 
in de klinische en pathologische diagnose van borstafwij-
kingen. Ongeveer 40% van de carcinomen, die bij het scree-
ningsonderzoek werden ontdekt, hadden een grootte van minder 
dan 1 cm, 60% was klinisch occult en 30% werd alleen op 
geleide van mammografische microcalcificaties gevonden. De 
chirurg moest gewend raken aan het biopteren van mammogra-
fisch verdachte maar klinisch occulte afwijkingen. De pa-
tholoog-anatoom op zijn beurt moest leren hoe biopten met 
mammografisch verdachte maar macroscopisch onzichtbare 
afwijkingen onderzocht moesten worden. Verder moest hij 
ervaring opdoen met de grensgevallen tussen benigne en 
maligne lesies, omdat vele van hen juist in de groep van 
klinisch occulte afwijkingen bleken voor te komen. Een 
methode van naaldlokalisatie, gevolgd door specimen-radio-
grafie, werd toegepast om de klinisch occulte afwijkingen te 
kunnen biopteren. Het specimen-radiogram bleek een voor-
treffelijk hulpmiddel te zijn bij het uitsnijden van weef-
selblokjes en het bepalen van de plaats van de afwijkingen 
en hun uitgebreidheid. Bij de diagnose van lesies, die ofwel 
kleiner waren dan 5 mm of die alleen op grond van mammogra-
fische microcalcificaties ontdekt werden, bleek de vries-
coupeprocedure slechts een beperkte rol te kunnen spelen. 
Voor het pathologische onderzoek van mastectomie-pre-
paraten werd een gekoppelde histologische en radiologische 
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methodiek gebruikt. Hiermee kunnen nauwkeurige en reprodu-
ceerbare gegevens verkregen worden over zowel uitbreiding 
als lokalisatie van de verschillende afwijkingen in de mamma 
alsook over hun topografische relatie ten opzichte van 
elkaar (hoofdstuk 1). 
De onderwerpen van deze dissertatie werden gekozen op 
grond van een aantal praktische problemen ten aanzien van 
diagnose en therapie van borstkanker. 
In hoofdstuk 2 wordt een pathologische en radiologische 
analyse gegeven van 64 zogenaamde intervalcarcinomen, die na 
1, 2 of 3 negatieve screenings-onderzoeken van het bevol-
kingsonderzoek werden ontdekt. De eigenlijke studiegroep 
omvatte 25.900 vrouwen uit Nijmegen die sinds 1975 aan dit 
onderzoek deelnamen. Volgens het programma werd elke 2 jaar 
één enkel overzichtsmammogram (latero-mediale projectie) 
vervaardigd. Verder klinisch onderzoek van de mamma werd 
niet verricht. 
Alle reeds aanwezige histologische coupes en mammo-
grammen van de 64 patiënten met een intervalcarcinoom werden 
opnieuw bekeken. In 19 van hen werden bij deze revisie 
directe dan wel indirecte aanwijzingen voor de tumor op het 
voorafgaande mammogram aangetroffen (waarnemersfout). In 4 
gevallen lag de lokalisatie van de tumor buiten het opname-
gebied (technische fout). In 41 gevallen was het niet moge-
lijk om enig teken van de tumor op het mammogram te ont-
dekken. Op grond van de berekende tumorverdubbelingstijd 
waren 20 van deze 41 tumoren waarschijnlijk te klein om bij 
de laatste screening ontdekt te kunnen worden ("echte" 
intervalcarcinomen). Daarentegen waren 21 tumoren wel groot 
genoeg geweest maar waren zij om een of andere reden bij het 
radiologische onderzoek onopgemerkt gebleven. De voornaamste 
redenen hiervoor waren: (1) een dichte borst, (2) een slecht 
omschreven tumormassa van een diffuus infiltratief type, dat 
vooral bij de invasieve lobulaire carcinomen voorkomt en (3) 
een intraductale lokalisatie. Vrouwen met dichte borsten 
zouden derhalve vaker moeten worden gescreend en dan met 
meer opnames en ruimere criteria voor het nemen van een 
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chirurgisch biopt. Verder wordt er op gewezen dat een twee-
jaarlijks interval tussen screenings-onderzoeken wel eens te 
lang zou kunnen zijn. 
Hoofdstuk 3 omvat een pathologische en radiologische 
studie van mammografisch occulte borstcarcinomen. De ge-
voeligheid van de mammografie bij het ontdekken van een 
carcinoom in symptomatische patiënten varieert volgens 
recente publikaties van 81 tot 96%. Van de 4 tot 19% fout-
negatieve mammogrammen zou bij revisie minstens de helft op 
een onjuiste mammografische diagnose berusten. De overige 
fout-negatieve diagnoses betreffen een groep carcinomen die 
mammografisch echt occult zijn, dat wil zeggen dat zij op 
het voorafgaande mammogram ook retrospectief niet ontdekt 
kunnen worden. Deze tumoren hebben immers geen duidelijke 
mammografische kenmerken. 
In deze studie werden 15 mammografisch occulte borst-
carcinomen (3 preinvasief en 12 invasief) en 52 carcinomen, 
die mammografisch alleen microcalcificaties te zien gaven 
zonder tumorschaduw (33 preinvasief, 19 invasief) histo-
pathologisch en radiologisch gereviseerd. De studie liet 
zien dat het merendeel van de preinvasieve tumoren zonder 
mammografisch duidelijke calcificaties, en sommige invasieve 
tumoren in dichte borsten, mammografisch occult kunnen zijn. 
De gemiddelde diameter van de 5 gevonden mammografisch 
occulte invasieve ductale carcinomen en de 5 invasieve 
lobulaire carcinomen was respectievelijk 20 en 50 mm. Dat 
invasieve lobulaire carcinomen mammografisch occult kunnen 
zijn, zelfs in een gevorderd stadium, zou histologisch 
verklaard kunnen worden door hun diffuus invasief patroon en 
vaak ook door een geringere desmoplastische reactie in 
vergelijking met die van de invasieve ductale carcinomen. 
Het meest belangrijke gevolg van het mammografisch 
occult-zijn van tumoren zal vaak een vertraging van de 
diagnose en de behandeling kunnen veroorzaken. De huidige 
studie onderzoekt de gevolgen van deze occulte tumoren voor 
te volgen procedures bij zowel symptomatische als asympto-
matische patiënten. 
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Om het aantal fout-negatieve mairanogrammen zoveel moge-
lijk te beperken, zou het aanbevelingswaardig zijn om: 
1. In elk mammografisch verslag melding te maken van de 
graad van dichtheid van de borst en daarmee de mate van 
betrouwbaarheid van de diagnose. 
2. Bij dichte borsten meer mammogrammen te maken waarbij ook 
vergrotingsopnames en verder, naast de film of xero-
mammografie, ook andere radiodiagnostische methodieken te 
gebruiken zoals echografie. 
3. In gedachten te houden dat fysisch onderzoek van de mamma 
een aantal van de kleinere tumoren aan het licht kan 
brengen die bij de mammografie zouden zijn gemist; daarom 
zou het fysisch onderzoek als een screeningsmethode naast 
de mammografie overwogen moeten worden. 
4. Van elke vrouw tussen de 35 en 40 jaar een zogenaamd 
base-line mammogram te maken dat dan vergeleken kan 
worden met de mammogrammen op het moment dat zij voor de 
eerste keer gescreend dan wel symptomatisch wordt. 
5. Zich te realiseren dat mammografisch onderzoek alleen 
uitgevoerd zou mogen worden met gebruikmaking van de 
meest geavanceerde technieken en uitsluitend door hoog-
gekwalificeerd en toegewijd personeel. 
In hoofdstuk 4 worden 6 gevallen van borsttumoren met 
osteoclast-achtige reuscellen besproken. Behalve de reeds 
eerder beschreven meerkernige reuscellen en aanzienlijke 
angiogenese in het stroma hebben wij bij deze tumoren de 
volgende karakteristieke kenmerken gevonden: 
1. Het macroscopisch aspect van een goedomschreven donker-
bruine tumormassa. 
2. Een ronde schaduw van de tumor op het mammogram, aan-
vankelijk geïnterpreteerd als een cyste, fibroadenoom of 
een medullair carcinoom. 
3. Een "adenocystisch" patroon van de invasieve tumorgroei. 
De licht- en electronenmicroscopische waarnemingen 
wijzen op een nauwe relatie tussen tumorcelgroepjes en de 
reuscellen en verlenen verdere steun aan de theorie dat deze 
laatste zich uit monocytaire histiocyten ontwikkelen als een 
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reactie op de produktie van een of ander extracellulair 
materiaal door de tumorcellen. Een totaal van 26 positieve 
axillaire klieren van 3 patiënten en vele intramammaire 
lymphvaten met tumorthrombi in 2 van hen bevatten reuscel-
len. Deze waarnemingen wijzen er op dat de benigne reus-
cellen een nagenoeg onafscheidelijk deel van de invasieve 
tumorgroei uitmaken. 
De 6 gevallen maken deel uit van een reeks van 527 
opeenvolgende borsttumoren die in een periode van 4 jaar, in 
een populatie van 75.000 volwassen vrouwen werden ontdekt. 
Deze gegevens doen twijfelen of deze bijzondere variant van 
het mammacarcinoom wel zo zeldzaam is als beschreven. 
Hoofdstuk 5 behandelt de multifocaliteit van carcino-
men in mastectomie-preparaten die met behulp van gelijktijdig 
uitgevoerde specimen-radiografie en histologische technieken 
onderzocht werden. De patiënten, die voor deze studie werden 
uitgekozen, waren vergelijkbaar met hen die algemeen als 
geschikt beschouwd kunnen worden voor borstsparende chirur-
gische therapie. Twee studiegroepen, de ene met 282 inva-
sieve carcinomen, de andere met 32 intraductale carcinomen, 
werden geselecteerd uit een groep van 399 opeenvolgende 
carcinomen en wel door die patiënten uit te sluiten die 
duidelijk geen candidaat waren voor een borstsparende chi-
rurgische therapie volgens de criteria van lopende trials. 
De niet in het onderzoek betrokken patiënten omvat-
ten hen met klinische en/of radiologische multifokale tu-
moren en hen met ingroei van de tumor in de borstwand of 
huid (7%). Ook uitgesloten werden de patiënten met dif-
fuse invasieve tumoren (8%), de klinisch en radiologisch 
occulte tumoren (3%) en de invasieve tumoren groter dan 5 cm 
(3%). Honderdvijf van de 282 invasieve tumoren (37%) toonde 
rond de referentietumor geen tumorfoci in het mastectomie-
preparaat. In 56 gevallen (20%) waren tumorfoci aanwezig 
binnen 2 cm afstand van de referentietumor en in 121 ge-
vallen (43%) waren zij te vinden op meer dan 2 cm hiervan-
daan. In 75 gevallen (27%) van deze laatste groep waren de 
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tumorfoci histologisch niet-invasief en in 46 gevallen (16%) 
bevatten zij invasieve haarden. 
Een vergelijking tussen de ene groep met referentietu-
moren kleiner dan 2 cm en de andere met tumoren groter dan 
2 cm leverde geen significante verschillen op ten aanzien 
van de aan- of afwezigheid van tumorfoci dan wel de afstand 
van de tumorfoci tot de referentietumor. 
Wanneer de 264 invasieve tumoren van 4 cm of kleiner 
met een rand van 3 tot 4 cm verwijderd zouden zijn, dan zou 
in 5 tot 9% van de patiënten een invasieve haard in de borst 
achtergebleven zijn. In een andere 4 tot 9% van de patiënten 
zouden de foei niet-invasief geweest zijn. 
Op basis van de gegevens van de verspreiding van tumor-
foci op verschillende afstand van de referentietumor, werd 
een schatting gemaakt van de verwachte frequentie van de 
lokale recidieven na borstsparende chirurgische ingrepen 
afhankelijk van de omvang van de excisie. Besproken wordt de 
mogelijke invloed van de postoperatieve lokale radiotherapie 
op de frequentie van het ontstaan van lokale recidieven. 
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STELLINGEN 
1. In elk mammografisch verslag moet de graad van dicht-
heid van de borst vermeld worden als een maatstaf voor 
de betrouwbaarheid van de diagnose. 
Hall FM, Radiology 1980; 136:258. 
2. Bij lesies, die ofwel alleen op grond van mammografische 
microcalcificaties worden ontdekt dan wel kleiner zijn 
dan 5 mm, speelt de vriescoupe-diagnostiek slechts een 
beperkte rol. 
3. Wat multifocaliteit betreft, lijkt er geen significant 
verschil te zijn tussen de borstcarcinomen die kleiner 
dan wel groter dan 2 cm zijn. 
4. In tegenstelling tot de amorfe calcificaties bij het 
intraductale carcinoom met centrale necrose, zijn de 
calcificaties bij het cribriforme en klein-papillaire 
type vooral kristallijn, en mammografisch als ronde 
puntjes zichtbaar. Omdat in vele benigne lesies de cal-
cificaties ook kristallijn zijn, kunnen deze tot een 
fout-negatieve diagnose leiden. 
5. Hoewel de WHO klassificatie van borstcarcinomen (Am J 
Clin Pathol 1982; 78:806) over het algemeen goed bruik-
baar is, gaat deze toch wel aanzienlijk voorbij aan 
het feit dat vele tumoren als een combinatie van ver-
schillende histologische typen optreden. Het kunnen 
vinden van de componenten hangt in grote mate af van 
het aantal onderzochte weefselblokjes. 
6. Nauwe samenwerking tussen clinicus en patholoog-ana-
toom bevordert een exacte denkwijze bij de clinicus 
en een verstandige denkwijze bij de patholoog-anatoom. 
7. Het verwerven van de kundigheid om 95% van het mate-
riaal, dat in een chirurgisch-pathologisch instituut 
wordt aangeboden, te diagnostiseren, vergt ëên jaar of 
minder. Om de resterende 5% goed te kunnen diagnosti-
seren zal men minstens de rest van zijn loopbaan nodig 
hebben. 
Coulson WF, Div. of Surg. Pathol. Univ. of California, 
Los Angeles. 
β. Zogenaamde "borderline-lesies" bestaan niet, alleen 
"borderline patholoog-anatomen" bestaan. 
Gallager HS, Inst, of Pathol., M.D. Anderson Hospi­
tal, Texas. 
De auteur van deze thesis zou dan ook een van hen zijn. 
9. Wanneer het niveau van de wetenschappelijke prestaties 
wordt gehanteerd als de meest belangrijke maatstaf voor 
het beoordelen van het functioneren van academische 
ziekenhuizen, zou dit voor de patient wel eens nadelig 
kunnen uitwerken. Wetenschappelijke prestaties op hoog 
niveau zijn namelijk lang niet altijd een garantie voor 
patiëntenzorg op hoog niveau. Het omgekeerde geldt even-
zeer. 
10. Het is voor een niet geboren en getogen Nederlander 
volstrekt onbegrijpelijk en ook taalkundig moeilijk 
te verklaren waarom het geslacht van het beest ver-
andert wanneer je de beest uithangt. 
Nijmegen, 20 juni 1984 
R. Holland 


